Cramp and spasm

R18_CRAMP_SPASM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R25.2 Cause of death: ICD-10 — R25.2 2 out of 7 registries used, show all original rules.	1864
4. Check minimum number of events None	1864
5. Include endpoints None	1864
6. Filter based on genotype QC (FinnGen only)	1799

Control definitions (FinnGen only)

Control exclude: CD2_BENIGN_FEMALE_GEN_OTH

Extra metadata

Level in the ICD hierarchy: 4
Special: MUSCLECRAMPS
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R25
Name in latin: Crampus

NAME	R18_CRAMP_SPASM
CONTROL_EXCLUDE	CD2_BENIGN_FEMALE_GEN_OTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R252
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R252
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cramp and spasm based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1799	1017	782
Unadjusted period prevalence (%)	0.36	0.36	0.36
Median age at first event (years)	54.64	51.40	58.86

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1864: Matched controls
18640

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R25.2

ICD-10 Finland

Cramp and spasm

+∞

307.7

1864

N03AE01

ATC

clonazepam; systemic

8.7

244.8

343

469

R56.8

ICD-10 Finland

Other and unspecified convulsions

8.1

197.3

290

416

N03AX16

ATC

[U] pregabalin

3.3

124.5

661

2642

N03AX12

ATC

[U] gabapentin; oral

3.6

122.7

513

1763

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.7

119.8

317

783

AA1AD

NOMESCO Finland

CT of head and brain

3.0

101.7

670

2975

M03BX01

ATC

baclofen; systemic

9.0

94.4

120

142

N05BA01

ATC

diazepam; systemic, rectal

3.4

87.3

380

1315

R51.80

ICD-10 Finland

Headache

3.1

85.7

458

1788

R25.3

ICD-10 Finland

Fasciculation

33.4

81.0

N04BC05

ATC

pramipexole; oral

4.2

80.4

237

628

M79.6

ICD-10 Finland

Pain in limb

2.5

80.0

950

5495

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

77.5

660

3261

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.9

76.7

144

261

M03BC01

ATC

orphenadrine (citrate); systemic

2.6

75.5

586

2762

N03AF02

ATC

oxcarbazepine; oral

5.9

72.7

137

249

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.4

70.6

283

922

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

70.4

840

4790

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.5

69.2

179

428

M03BX02

ATC

tizanidine; oral

2.5

67.7

1312

9159

M79.1

ICD-10 Finland

Myalgia

2.8

64.7

394

1628

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.0

64.5

198

538

N03AG01

ATC

valproic acid; systemic, rectal

4.0

64.4

199

543

N02AX02

ATC

tramadol; systemic, rectal

2.3

64.0

918

5593

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.2

64.0

290

1016

R53

ICD-10 Finland

Malaise and fatigue

2.5

64.0

573

2855

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

63.8

942

5805

G24.9

ICD-10 Finland

Dystonia, unspecified

25.0

62.3

N06AX21

ATC

duloxetine; oral

2.9

61.2

326

1251

R42

ICD-10 Finland

Dizziness and giddiness

2.5

61.2

508

2438

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

59.2

317

1219

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

58.6

452

2091

R55

ICD-10 Finland

Syncope and collapse

3.1

58.1

280

1014

A02BC02

ATC

pantoprazole; systemic

2.3

57.5

1344

9807

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.4

57.0

550

2810

A01

ICPC

Pain general/multiple sites

3.1

55.0

253

890

M54.5

ICD-10 Finland

Low back pain

2.1

54.3

791

4761

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.2

53.8

149

374

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

52.5

612

3365

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

51.1

363

1604

N05AH04

ATC

quetiapine; oral

2.4

50.6

436

2106

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

50.5

420

1996

Z3231

NOMESCO Finland

Registered nurse

2.2

50.5

597

3292

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

50.2

439

2134

R20.2

ICD-10 Finland

Paraesthesia of skin

3.3

50.0

205

672

R11

ICD-10 Finland

Nausea and vomiting

3.1

49.9

231

814

L17

ICPC

Foot/toe symptom/complaint

2.2

49.5

615

3454

N05BA04

ATC

oxazepam; oral

2.2

49.3

570

3111

N03AX14

ATC

levetiracetam; systemic

5.2

48.1

101

202

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.7

47.8

163

474

N06AX11

ATC

mirtazapine; oral

2.1

47.8

714

4289

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.1

47.7

224

795

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

11.4

47.7

XA800

NOMESCO Finland

Neuropsychological investigation

4.0

46.7

141

377

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.5

45.9

351

1599

S06.0

ICD-10 Finland

Concussion

2.7

45.8

281

1151

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

45.7

239

900

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.6

45.2

303

1297

N03AX09

ATC

lamotrigine; oral

3.6

44.9

156

459

TAB00

NOMESCO Finland

Lumbar puncture

3.8

44.5

144

404

R52.2

ICD-10 Finland

Other chronic pain

4.2

43.9

120

298

H02AB06

ATC

prednisolone; systemic

2.0

43.7

939

6353

M25.5

ICD-10 Finland

Pain in joint

2.0

43.5

685

4162

R07.3

ICD-10 Finland

Other chest pain

2.7

42.8

254

1022

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

42.8

345

1607

N02BF01

ATC

gabapentin; oral

3.0

42.6

210

765

N02BE01

ATC

paracetamol; systemic, rectal

3.0

42.4

1702

14470

R52.9

ICD-10 Finland

Pain, unspecified

2.8

42.1

240

945

R25.1

ICD-10 Finland

Tremor, unspecified

4.8

41.2

206

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

41.0

429

2226

N06AX16

ATC

venlafaxine; oral

2.4

40.7

345

1639

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

40.4

351

1686

L01

ICPC

Neck symptom/complaint

2.3

40.3

354

1707

N02BF02

ATC

pregabalin; oral

3.3

39.7

159

512

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.2

39.6

168

560

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

5.8

39.6

133

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

5.4

39.1

149

N06AA09

ATC

amitriptyline; systemic

2.8

38.7

218

852

R06.0

ICD-10 Finland

Dyspnoea

2.0

38.5

538

3107

N05CF01

ATC

zopiclone; oral

2.0

38.5

624

3796

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

38.3

885

6045

N17

ICPC

Vertigo/dizziness

2.5

38.3

267

1159

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

38.2

248

1041

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.0

38.1

181

644

G72.9

ICD-10 Finland

Myopathy, unspecified

9.6

38.1

G44.2

ICD-10 Finland

Tension-type headache

2.3

37.8

317

1496

N01

ICPC

Headache

2.4

37.2

283

1279

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

36.3

296

1378

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

36.1

392

2053

A02BC05

ATC

esomeprazole; systemic

1.9

36.1

782

5205

X58

ICD-10 Finland

Exposure to other specified factors

2.2

35.6

334

1649

S18

ICPC

Laceration/cut

1.8

35.5

868

5988

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

35.3

308

1476

J01FF01

ATC

clindamycin; systemic

2.0

35.2

552

3302

R4120

NOMESCO Finland

Occupational therapy

3.0

35.0

169

607

L03

ICPC

Low back symptom/complaint

1.9

34.9

567

3430

Z3226

NOMESCO Finland

Physiotherapist

2.1

34.9

389

2057

R4110

NOMESCO Finland

Physiotherapy

1.9

34.8

552

3313

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

34.7

409

2207

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

34.7

590

3622

N06AB04

ATC

citalopram; systemic

2.1

34.0

425

2342

N03AF01

ATC

carbamazepine; oral, rectal

3.3

34.0

134

427

C07AA05

ATC

propranolol; systemic

2.0

33.8

442

2477

R02

ICPC

Shortness of breath/dyspnoea

2.3

33.6

276

1287

C07AB07

ATC

bisoprolol; oral

1.8

33.4

848

5886

L28

ICPC

Limited function/disability (L)

2.2

33.2

337

1714

N02AA05

ATC

oxycodone; systemic

2.2

33.0

337

1718

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

33.0

832

5755

XF600

NOMESCO Finland

Bloodpressure measurement

3.0

32.9

154

543

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.8

31.8

101

279

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

31.4

688

4546

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

31.2

519

3146

N05AH03

ATC

olanzapine; systemic

2.8

31.1

169

646

WX892

NOMESCO Finland

Monitored bed care

2.7

31.1

182

723

Z71.8

ICD-10 Finland

Other specified counselling

1.8

30.8

623

4011

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

30.6

198

826

A02BC01

ATC

omeprazole; systemic

1.9

30.6

518

3154

Z2221

NOMESCO Finland

Medical doctor

1.9

30.4

549

3411

A04

ICPC

Weakness/tiredness general

2.1

30.1

311

1589

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.9

30.0

248

Z2445

NOMESCO Finland

Psychologist

3.3

30.0

116

365

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

30.0

237

1084

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

29.9

191

792

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

29.6

427

2461

A28

ICPC

Limited function/disability NOS

2.2

29.5

299

1515

P19

ICPC

Drug abuse

7.7

29.4

M01AB05

ATC

diclofenac; systemic, rectal

1.8

28.9

1229

9732

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.9

28.7

131

A06AD11

ATC

lactulose; oral

2.2

28.6

268

1315

N06AB10

ATC

escitalopram; oral

1.9

28.6

435

2549

Z2446

NOMESCO Finland

Social worker

2.7

28.6

165

650

M54.8

ICD-10 Finland

Other dorsalgia

3.2

28.6

116

376

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.1

28.4

122

409

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

28.0

380

2142

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

27.8

207

921

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.0

27.8

123

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

27.6

204

904

R96

ICPC

Asthma

2.4

27.4

202

895

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

27.2

446

2672

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

26.9

208

940

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

26.8

239

1148

A11

ICPC

Chest pain NOS

2.5

26.5

171

711

A02BC03

ATC

lansoprazole; oral

1.8

26.2

526

3351

H53.1

ICD-10 Finland

Subjective visual disturbances

2.7

26.1

151

595

ZXD05

NOMESCO Finland

Urgent procedure

1.8

26.1

588

3873

R60.0

ICD-10 Finland

Localized oedema

2.2

26.0

235

1134

J01DB01

ATC

cefalexin; oral

2.0

25.9

1552

13360

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

25.9

364

2071

WX002

NOMESCO Finland

Sedation and analgesia

1.9

25.8

374

2148

R03AC02

ATC

salbutamol; inhalant

1.7

25.8

1039

7987

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

4.1

25.8

177

R03DC03

ATC

montelukast; oral

2.0

25.7

342

1908

D06

ICPC

Abdominal pain localized other

2.4

25.6

186

817

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

25.6

594

3940

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

25.6

561

3662

D01

ICPC

Abdominal pain/cramps general

2.2

25.5

253

1267

R33

ICD-10 Finland

Retention of urine

2.6

25.5

157

638

R06.4

ICD-10 Finland

Hyperventilation

5.0

25.4

113

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

25.3

438

2664

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.5

25.2

171

728

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

25.1

522

3353

N03AX11

ATC

topiramate; oral

4.0

25.0

190

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.6

24.8

147

586

XA402

NOMESCO Finland

ENMG

4.1

24.7

174

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

24.6

266

1376

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

24.6

796

5758

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

24.5

143

566

R00.2

ICD-10 Finland

Palpitations

2.4

24.4

173

752

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

24.2

225

1097

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.2

24.0

160

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

24.0

149

608

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

24.0

156

651

M79.7

ICD-10 Finland

Fibromyalgia

3.4

23.8

264

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.4

23.8

140

A29

ICPC

General symptom/complaint other

2.1

23.6

245

1247

R06AE07

ATC

cetirizine; oral

1.6

23.5

821

6033

S21

ICPC

Skin texture symptom/complaint

2.0

23.5

272

1441

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.9

23.4

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.5

23.4

247

K30

ICD-10 Finland

Functional dyspepsia

2.2

23.4

229

1140

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.4

23.3

134

L19

ICPC

Muscle symptom/complaint NOS

3.7

23.2

210

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.1

23.1

101

342

L12

ICPC

Hand/finger symptom/complaint

1.9

23.0

321

1815

R50.9

ICD-10 Finland

Fever, unspecified

2.0

23.0

303

1681

N30.0

ICD-10 Finland

Acute cystitis

2.0

22.7

301

1672

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

22.7

275

1481

N05CD07

ATC

temazepam; oral

2.2

22.7

209

1015

M48.0

ICD-10 Finland

Spinal stenosis

2.1

22.7

226

1132

T78.4

ICD-10 Finland

Allergy, unspecified

2.9

22.7

110

395

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

22.7

477

3060

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.9

22.5

112

408

M54.6

ICD-10 Finland

Pain in thoracic spine

2.4

22.3

166

736

ZXA05

NOMESCO Finland

Left side

1.8

22.1

436

2744

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.8

22.0

107

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

22.0

402

2472

ZY010

NOMESCO Finland

Hospital outpatient

2.7

22.0

126

494

N07

ICPC

Convulsion/seizure

29.4

21.9

P01AB01

ATC

metronidazole; oral, rectal

1.6

21.9

728

5261

C03CA01

ATC

furosemide; systemic

1.7

21.8

460

2948

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

21.7

681

4847

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

21.6

195

938

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

21.5

293

1641

J02AC01

ATC

fluconazole; systemic

1.6

21.3

706

5086

XF402

NOMESCO Finland

ECG with work load test

2.2

21.3

197

958

J01FA06

ATC

roxithromycin; oral

1.6

21.1

715

5176

M54.3

ICD-10 Finland

Sciatica

2.6

21.0

130

529

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

21.0

1329

11169

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

21.0

641

4523

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

21.0

510

3394

L02

ICPC

Back symptom/complaint

2.1

20.9

210

1055

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

20.8

279

1554

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

20.7

218

1113

P06

ICPC

Sleep disturbance

2.0

20.7

242

1284

XF404

NOMESCO Finland

Ambulatory ECG

2.3

20.6

170

788

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.7

20.6

179

N05AA02

ATC

levomepromazine; systemic

3.0

20.6

321

J01MA02

ATC

ciprofloxacin; systemic

1.6

20.6

680

4887

UJF32

NOMESCO Finland

Coloscopy

1.7

20.6

451

2916

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

20.5

130

536

ZXE00

NOMESCO Finland

One hour or less

1.6

20.4

708

5144

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

20.4

103

378

F29

ICPC

Eye symptom/complaint other

2.2

20.0

187

912

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.2

20.0

252

H57.1

ICD-10 Finland

Ocular pain

3.0

19.7

307

W19

ICD-10 Finland

Unspecified fall

2.1

19.7

195

973

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.9

19.6

324

N05BA09

ATC

clobazam; oral

7.5

19.5

R03BA05

ATC

fluticasone; inhalant

1.8

19.5

347

2109

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

19.5

384

2404

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

19.4

288

1655

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.7

19.3

168

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.8

19.3

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

19.3

876

6750

N06AB03

ATC

fluoxetine; oral

2.0

19.3

245

1338

R03BB04

ATC

tiotropium bromide; inhalant

2.1

19.2

190

948

N07BB01

ATC

disulfiram; oral

2.8

19.1

368

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

19.1

235

1268

H02AB07

ATC

prednisone; oral

1.9

19.1

249

1372

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

19.0

208

1076

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.2

19.0

244

R13

ICD-10 Finland

Dysphagia

2.4

19.0

141

624

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

19.0

440

2878

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

19.0

189

944

J01AA02

ATC

doxycycline; systemic

1.6

19.0

1368

11696

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

18.9

176

856

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.6

18.9

180

R51.81

ICD-10 Finland

Facial pain NOS

3.6

18.8

176

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.0

18.8

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.8

18.8

366

N05AX12

ATC

aripiprazole; systemic

2.8

18.8

372

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

18.7

134

584

N03AX18

ATC

lacosamide; systemic

6.8

18.7

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

18.7

178

874

N05BA02

ATC

chlordiazepoxide; systemic

3.6

18.7

172

L29

ICPC

Musculoskeletal sympt/complt other

2.2

18.7

163

773

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

18.6

961

7598

C01CA24

ATC

epinephrine; parenteral

2.3

18.5

147

670

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

18.4

1330

11327

M35.7

ICD-10 Finland

Hypermobility syndrome

4.6

18.3

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.0

18.2

129

ZXD35

NOMESCO Finland

Usual procedure

3.1

18.2

251

R35

ICD-10 Finland

Polyuria

2.4

18.1

131

573

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.3

18.1

108

J01EA01

ATC

trimethoprim; systemic

1.7

18.1

438

2894

M54.2

ICD-10 Finland

Cervicalgia

2.2

18.1

167

810

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

18.1

143

651

S80.0

ICD-10 Finland

Contusion of knee

2.2

18.0

154

724

WVA20

NOMESCO Finland

Medicine administration

3.4

18.0

201

N06AB06

ATC

sertraline; oral

1.9

17.9

235

1297

N88

ICPC

Epilepsy

7.0

17.8

R03AC03

ATC

terbutaline; inhalant

1.9

17.7

263

1509

L04

ICPC

Chest symptom/complaint

2.4

17.7

131

579

E0000UV, ,

ATC

1.5

17.6

743

5597

J46

ICD-10 Finland

Status asthmaticus

3.4

17.6

194

R01AD09

ATC

mometasone; nasal

1.5

17.5

826

6374

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

17.4

315

1919

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

6.1

17.3

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

21.1

17.3

L15

ICPC

Knee symptom/complaint

1.7

17.3

416

2742

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

17.2

439

2935

P99

ICPC

Psychological disorders other

3.1

17.2

243

R1250

NOMESCO Finland

Evaluation of functional capability

3.5

17.2

177

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.0

17.2

211

1137

R05

ICPC

Cough

1.6

17.1

435

2905

L86

ICPC

Back syndrome with radiating pain

2.4

17.1

125

550

R03BA01

ATC

beclometasone; inhalant

1.9

17.0

247

1406

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.3

17.0

203

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

17.0

119

513

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

17.0

996

8026

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

17.0

134

609

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.6

17.0

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.9

16.9

127

ZX120

NOMESCO Finland

Intravenous

2.1

16.9

177

900

K08.80

ICD-10 Finland

Toothache NOS

2.1

16.9

180

921

M01AH01

ATC

celecoxib; oral

1.8

16.9

302

1833

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

16.8

100

400

P18

ICPC

Medication abuse

5.8

16.7

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

16.6

362

2320

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

16.6

154

749

P15

ICPC

Chronic alcohol abuse

3.0

16.5

249

R52.1

ICD-10 Finland

Chronic intractable pain

5.6

16.5

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.5

16.5

109

458

D02

ICPC

Abdominal pain epigastric

2.3

16.5

123

546

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.3

16.5

S29

ICPC

Skin symptom/complaint other

1.7

16.5

335

2108

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.6

16.5

153

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.4

16.4

ZXA00

NOMESCO Finland

Right side

1.6

16.4

435

2933

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

16.3

270

1602

XQ800

NOMESCO Finland

Prick test

2.1

16.3

155

761

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

16.2

165

830

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.9

16.2

122

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

16.2

492

3426

R03BA02

ATC

budesonide; inhalant

1.7

16.2

327

2052

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

5.9

16.2

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

6.8

16.2

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

16.1

175

902

R51

ICD-10 Finland

Headache

2.3

16.1

119

526

B01AB05

ATC

enoxaparin; parenteral

1.6

16.1

528

3743

L08

ICPC

Shoulder symptom/complaint

1.7

16.0

380

2490

P29

ICPC

Psychological sympt/compl other

2.1

16.0

151

739

A27

ICPC

Fear of other disease NOS

2.5

15.9

398

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.0

15.9

233

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

14.6

15.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

15.8

221

1242

ZXA10

NOMESCO Finland

Bilateral

1.7

15.8

309

1922

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.5

15.8

394

A99

ICPC

Disease/condition unspecnature/site

2.0

15.7

175

910

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

15.7

913

7299

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

15.7

114

500

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.2

15.7

144

697

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.9

15.6

263

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

15.6

211

1174

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.1

15.5

108

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

15.5

151

747

N06AG02

ATC

moclobemide; oral

2.7

15.5

332

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.8

15.5

275

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.4

15.4

ZX114

NOMESCO Finland

Intramuscular

4.2

15.4

100

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

15.4

189

1018

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

15.3

219

1239

J45

ICD-10 Finland

Asthma

2.0

15.3

189

1019

SPAT1216

SPAT

Assessment of functional ability

1.8

15.3

252

1491

R5599

NOMESCO Finland

Other rehabilitation service

3.1

15.1

213

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

15.1

128

600

U02

ICPC

Urinary frequency/urgency

1.8

15.1

243

1428

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

15.0

314

1986

L14

ICPC

Leg/thigh symptom/complaint

2.1

15.0

147

729

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

15.0

142

695

SPAT1254

SPAT

Administration of medicine

1.8

14.9

255

1524

R21

ICPC

Throat symptom/complaint

1.6

14.9

397

2672

UKC02

NOMESCO Finland

Cystoscopy

1.8

14.9

260

1564

SPAT1301

SPAT

No procedures

1.5

14.9

529

3807

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

14.9

101

430

D11

ICPC

Diarrhoea

1.8

14.8

225

1298

L18

ICPC

Muscle pain

2.6

14.8

334

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

14.8

361

2378

N30.9

ICD-10 Finland

Cystitis, unspecified

2.3

14.7

113

508

R40.2

ICD-10 Finland

Coma, unspecified

6.2

14.7

M01AH05

ATC

etoricoxib; oral

1.5

14.6

1089

9090

183

Kela drug reimbursment

Lamotrigin and topiramate

5.7

14.6

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

14.6

223

1288

N05AX08

ATC

risperidone; systemic

2.1

14.6

150

758

K07.60

ICD-10 Finland

Snapping jaw

2.3

14.5

112

505

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

14.5

202

1134

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

14.5

408

2782

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

14.5

121

564

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

14.4

371

2473

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

14.4

127

604

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.4

14.4

157

A03

ICPC

Fever

1.7

14.4

318

2040

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.0

14.4

225

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

14.4

173

925

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

14.4

236

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

14.3

116

534

S22.3

ICD-10 Finland

Fracture of rib

2.1

14.3

139

688

F10.24

ICD-10 Finland

Alcohol depence active use

3.8

14.3

115

M54.1

ICD-10 Finland

Radiculopathy

2.6

14.2

329

U01

ICPC

Dysuria/painful urination

2.1

14.1

143

718

F44.4

ICD-10 Finland

Dissociative motor disorders

42.8

14.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

14.1

246

1478

D25

ICPC

Abdominal distension

3.6

14.1

130

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.9

14.1

107

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.6

14.1

307

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.0

14.1

171

917

G40

ICD-10 Finland

Epilepsy

5.0

14.1

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

14.0

300

1908

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.4

14.0

155

M01AH02

ATC

rofecoxib; oral

1.8

13.9

207

1185

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.2

13.9

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

13.9

412

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.7

13.8

275

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

13.7

635

4814

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

13.7

144

734

A02BA02

ATC

ranitidine; systemic

1.7

13.7

310

2001

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

5.0

13.6

G04CA02

ATC

tamsulosin; oral

1.6

13.6

357

2391

Z01.2

ICD-10 Finland

Dental examination

1.5

13.5

805

6401

N04BC04

ATC

ropinirole; oral

5.9

13.5

R03AC12

ATC

salmeterol; inhalant

2.5

13.5

331

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.2

13.5

R01AD08

ATC

fluticasone; nasal

1.5

13.5

499

3611

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.3

13.5

154

P01

ICPC

Feeling anxious/nervous/tense

1.8

13.4

237

1428

N06AX03

ATC

mianserin; oral

2.4

13.4

381

XCK00

NOMESCO Finland

Perimetry

2.3

13.3

102

458

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.9

13.3

178

985

M01AE02

ATC

naproxen; oral, rectal

1.4

13.3

1006

8355

S04

ICPC

Lump/swelling localized

1.9

13.3

189

1067

N29

ICPC

Neurological sympt/complt other

3.6

13.2

126

SPAT1153

SPAT

Removal of sutures

1.5

13.2

518

3790

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.3

13.2

146

N05CF02

ATC

zolpidem; oral

1.6

13.2

306

1986

R05

ICD-10 Finland

Cough

1.6

13.1

367

2492

L16

ICPC

Ankle symptom/complaint

1.8

13.0

209

1224

XKD00

NOMESCO Finland

Uroflowmetry

1.7

13.0

244

1495

R06AX27

ATC

desloratadine; oral

1.5

13.0

516

3783

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

13.0

214

1264

G25.2

ICD-10 Finland

Other specified forms of tremor

6.2

12.9

G43.3

ICD-10 Finland

Complicated migraine

3.4

12.9

133

R74

ICPC

Upper respiratory infection acute

1.5

12.9

582

4378

S01

ICPC

Pain/tenderness of skin

2.4

12.9

376

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

12.8

383

R07.0

ICD-10 Finland

Pain in throat

2.0

12.8

135

689

G47.3

ICD-10 Finland

Sleep apnoea

1.6

12.7

390

2702

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

12.7

737

5811

N05BA12

ATC

alprazolam; oral

1.9

12.7

179

1007

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.0

12.7

136

697

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

12.7

103

474

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

12.7

158

854

D07AC01

ATC

betamethasone; topical

1.5

12.7

600

4552

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.7

12.7

270

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.7

12.6

111

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

12.6

113

542

RS221, ,

NOMESCO Finland

3.8

12.6

102

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

12.6

177

996

A02BA04

ATC

nizatidine; systemic

2.1

12.6

124

617

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.3

12.5

412

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.6

12.5

301

Z00.0

ICD-10 Finland

General medical examination

1.6

12.5

336

2259

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

12.4

343

2318

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.9

12.4

210

G24.8

ICD-10 Finland

Other dystonia

13.3

12.4

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.4

12.4

K02.1

ICD-10 Finland

Caries of dentine

1.4

12.4

1062

8971

EBA00

NOMESCO Finland

Extraction of tooth

1.5

12.4

633

4870

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.7

12.4

C05AA08

ATC

fluocortolone; rectal, topical

1.7

12.4

225

1367

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.0

12.3

189

SPAT1229

SPAT

Assessment of need for aid

2.1

12.3

125

628

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

12.3

165

913

D10

ICPC

Vomiting

2.1

12.3

119

587

G56.3

ICD-10 Finland

Lesion of radial nerve

5.4

12.3

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

12.3

114

554

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

12.2

124

623

SPAT1240

SPAT

Therapeutic discussion

1.8

12.2

205

1216

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

12.2

275

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

12.2

670

5219

N04AA02

ATC

biperiden; systemic

3.4

12.2

128

E86

ICD-10 Finland

Volume depletion

3.3

12.2

143

A92

ICPC

Allergy/allergic reaction NOS

2.7

12.2

258

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

12.2

177

1006

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

5.3

12.0

N89

ICPC

Migraine

2.4

12.0

332

F41.00

ICD-10 Finland

Moderate panic disorder

3.5

12.0

115

G24.3

ICD-10 Finland

Spasmodic torticollis

4.3

12.0

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

4.0

11.9

A07AA02

ATC

nystatin; oral

2.2

11.9

100

467

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

11.9

111

541

N06AX26

ATC

vortioxetine; oral

1.9

11.9

142

757

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.0

11.8

183

L20

ICPC

Joint symptom/complaint NOS

2.6

11.8

274

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.3

11.7

392

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

9.7

11.7

WYA10

NOMESCO Finland

Emergency care or similar visit

2.0

11.7

139

739

J01MA12

ATC

levofloxacin; systemic

1.6

11.7

299

1983

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

11.7

324

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.6

11.6

103

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

11.6

337

R49.08

ICD-10 Finland

Other specified dysphonia

3.1

11.6

158

SFA20

NOMESCO Finland

Two-surface restoration

1.4

11.6

1036

8771

J01FA10

ATC

azithromycin; systemic

1.4

11.6

1016

8574

G25.3

ICD-10 Finland

Myoclonus

23.0

11.6

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.6

11.5

248

J01CA04

ATC

amoxicillin; systemic

1.5

11.5

1478

13363

N05CD08

ATC

midazolam; nasal, systemic

3.1

11.5

159

D19

ICPC

Teeth/gum symptom/complaint

1.5

11.5

492

3649

ACC53

NOMESCO Finland

Release of ulnar nerve

3.6

11.5

104

J01FA09

ATC

clarithromycin; systemic

1.5

11.4

535

4036

M02AA10

ATC

ketoprofen; topical

1.7

11.4

252

1613

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.4

11.4

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.0

11.3

171

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.0

11.3

166

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

11.3

354

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

11.3

129

677

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

11.3

187

1105

N06AA12

ATC

doxepin; systemic

2.2

11.3

425

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.6

11.3

239

C08DB01

ATC

diltiazem; oral

2.4

11.3

311

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

4.4

11.2

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

11.2

224

1394

K29

ICPC

Cardiovascular sympt/complt other

2.5

11.2

293

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

11.2

192

1147

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

11.2

166

950

N99

ICPC

Neurological disease other

4.1

11.1

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

11.1

116

K59.0

ICD-10 Finland

Constipation

2.2

11.1

454

N06AX17

ATC

milnacipran; oral

4.2

11.1

R01AD58

ATC

fluticasone, combinations; nasal

1.5

11.1

425

3080

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

11.1

156

878

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

11.0

188

1120

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

11.0

435

3171

NXL00

NOMESCO Finland

Biopsy of muscle

9.3

11.0

L13

ICPC

Hip symptom/complaint

1.6

11.0

283

1879

N05BE01

ATC

buspirone; oral

2.6

10.9

237

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.1

10.9

148

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

10.9

366

WX290

NOMESCO Finland

Other blockage of nerve

1.4

10.9

847

6975

SPAT1263

SPAT

Sampling

1.4

10.8

702

5604

R10.0

ICD-10 Finland

Acute abdomen

2.6

10.8

244

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.2

10.8

J05AB11

ATC

valaciclovir; oral

1.6

10.8

241

1544

H02AB04

ATC

methylprednisolone; systemic

1.7

10.8

234

1488

D09

ICPC

Nausea

2.2

10.8

433

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

10.8

394

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.1

10.7

101

494

J01DA01

ATC

[U] cefalexin

1.4

10.7

1059

9064

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

10.7

139

762

WX730

NOMESCO Finland

Conventional respirator

3.7

10.7

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

10.7

441

W17

ICD-10 Finland

Other fall from one level to another

2.3

10.7

363

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.5

10.6

264

C03DA01

ATC

spironolactone; oral

1.7

10.6

184

1101

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

10.6

136

742

J20

ICD-10 Finland

Acute bronchitis

1.8

10.6

174

1026

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

10.6

198

1211

R49.01

ICD-10 Finland

Functional dysphonia

2.6

10.6

241

R15

ICD-10 Finland

Faecal incontinence

2.9

10.5

173

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

10.5

199

1221

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.7

10.5

S10

ICPC

Boil/carbuncle

2.1

10.5

105

526

N06AA10

ATC

nortriptyline; systemic

2.9

10.5

168

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

10.5

123

652

P16

ICPC

Acute alcohol abuse

3.2

10.5

131

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.4

10.4

297

C08DA01

ATC

verapamil; systemic

2.4

10.4

322

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

10.4

694

5555

RS222, ,

NOMESCO Finland

4.1

10.4

S02

ICPC

Pruritus

2.4

10.4

285

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

10.4

329

A01AB09

ATC

miconazole; local oral

1.9

10.4

140

777

-60

ICPC

Result test/procedure

2.1

10.3

101

501

C07AB02

ATC

metoprolol; systemic

1.6

10.3

292

1979

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

10.3

152

867

N05AF03

ATC

chlorprothixene; systemic

2.8

10.3

192

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.4

10.3

287

-59

ICPC

Other therap proced/minor surg NEC

2.7

10.2

204

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

10.2

449

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

10.2

429

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

10.2

230

1476

Z08

ICPC

Social welfare problem

3.6

10.2

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.6

10.2

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

10.2

387

2794

WX402

NOMESCO Finland

General anaesthesia

1.5

10.2

355

2519

C10AX09

ATC

ezetimibe; oral

1.6

10.2

241

1567

M10.9

ICD-10 Finland

Gout, unspecified

2.0

10.2

109

560

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.9

10.1

130

710

SFA10

NOMESCO Finland

One-surface restoration

1.4

10.1

960

8130

R4110, ,

SPAT

1.8

10.1

141

791

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.8

10.1

183

R4130

NOMESCO Finland

Speech therapy

2.7

10.0

206

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.6

10.0

212

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

4.5

10.0

N18

ICPC

Paralysis/weakness

3.2

10.0

119

R1250, ,

SPAT

3.2

10.0

119

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

4.6

10.0

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

10.0

208

1308

H81.3

ICD-10 Finland

Other peripheral vertigo

2.8

10.0

184

M77.4

ICD-10 Finland

Metatarsalgia

2.0

10.0

110

571

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

9.9

159

930

R03BA08

ATC

ciclesonide; inhalant

1.8

9.9

155

900

XG466

NOMESCO Finland

Sleep oxymetry

2.6

9.9

225

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.0

9.9

146

XA400

NOMESCO Finland

EEG

7.7

9.9

G20

ICD-10 Finland

Parkinson disease

2.8

9.9

168

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.2

9.9

120

KMAK, ,

NOMESCO Finland

1.4

9.8

892

7487

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

20.1

9.8

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

4.9

9.8

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.8

9.8

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.3

9.8

300

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

9.8

319

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

9.8

343

2435

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

9.8

265

1779

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

4.1

9.7

M01AX17

ATC

nimesulide; oral

1.5

9.7

361

2594

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

9.7

216

K04.08

ICD-10 Finland

Other specified pulpit

1.8

9.7

145

832

L05

ICPC

Flank/axilla symptom/complaint

2.0

9.7

106

549

M02AA07

ATC

piroxicam; topical

1.4

9.6

542

4203

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.0

9.6

143

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

9.6

367

2649

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

9.6

105

543

PA6AD

NOMESCO Finland

CT of neck arteries

2.6

9.6

205

T78.3

ICD-10 Finland

Angioneurotic oedema

3.4

9.6

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

9.6

413

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.0

9.6

R04.2

ICD-10 Finland

Haemoptysis

2.5

9.6

247

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.9

9.6

149

L09

ICPC

Arm symptom/complaint

2.1

9.6

427

K07

ICPC

Swollen ankles/oedema

2.2

9.5

348

A08

ICPC

Swelling

2.1

9.5

414

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

2.0

9.5

108

566

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

9.5

291

SGA01

NOMESCO Finland

Emergency treatment

1.5

9.5

292

2014

G43.8

ICD-10 Finland

Other migraine

3.1

9.5

123

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

9.5

152

889

H29

ICPC

Ear symptom/complaint other

1.7

9.5

183

1128

R09.1

ICD-10 Finland

Pleurisy

3.2

9.5

118

-69

ICPC

Other reason for encounter NEC

2.3

9.4

311

P76

ICPC

Depressive disorder

1.9

9.4

122

668

R39.1

ICD-10 Finland

Other difficulties with micturition

2.6

9.4

213

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

9.4

497

3810

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.5

9.4

225

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

9.4

156

H53.2

ICD-10 Finland

Diplopia

2.4

9.4

268

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

9.4

492

N06AB05

ATC

paroxetine; oral

2.0

9.4

106

555

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

9.4

149

870

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.2

9.4

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

9.3

127

707

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

8.1

9.3

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.4

9.3

N05AH02

ATC

clozapine; systemic

3.0

9.3

135

F05.9

ICD-10 Finland

Delirium, unspecified

3.3

9.3

109

C01DA14

ATC

isosorbide mononitrate; oral

1.7

9.3

197

1244

M01AC06

ATC

meloxicam; systemic, rectal

1.4

9.3

569

4472

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.4

9.3

263

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.6

9.3

203

-1, ,

NOMESCO Finland

1.4

9.3

581

4585

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.6

9.2

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

9.2

434

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

9.1

135

771

E87.6

ICD-10 Finland

Hypokalaemia

2.4

9.1

265

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.4

9.1

265

F45.0

ICD-10 Finland

Somatization disorder

7.8

9.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

9.1

358

2596

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.8

9.1

159

J45.8

ICD-10 Finland

Mixed asthma

2.5

9.1

235

SPAT1260

SPAT

Consultation of another employee

1.5

9.1

278

1916

WX320

NOMESCO Finland

Spinalanesthesy

1.4

9.1

388

2861

N05AD01

ATC

haloperidol; systemic

2.6

9.0

194

S22

ICPC

Nail symptom/complaint

1.9

9.0

110

591

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

9.0

292

H92.0

ICD-10 Finland

Otalgia

1.9

9.0

107

570

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

9.0

170

1043

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.6

9.0

189

SPAT1104

SPAT

Monitoring of emergency patient

1.9

8.9

104

550

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

8.9

195

J05AB01

ATC

aciclovir; systemic

1.5

8.9

354

2571

G82.5

ICD-10 Finland

Tetraplegia, unspecified

18.7

8.9

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.1

8.9

439

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.3

8.9

300

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

8.9

242

1624

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

8.9

244

Z03

ICPC

Housing/neighbourhood problem

4.9

8.8

S01.0

ICD-10 Finland

Open wound of scalp

1.8

8.8

128

727

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.8

8.8

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

8.8

377

2779

C08CA01

ATC

amlodipine; oral

1.4

8.8

552

4350

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.7

8.7

174

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

7.2

8.7

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.3

8.7

277

SFA30

NOMESCO Finland

Three-surface restoration

1.4

8.7

704

5770

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.3

8.7

290

C10AA05

ATC

atorvastatin; oral

1.4

8.7

608

4875

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.2

8.7

109

G44.0

ICD-10 Finland

Cluster headache syndrome

3.4

8.6

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

3.8

8.6

N05AB03

ATC

perphenazine; systemic, rectal

2.3

8.6

285

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.9

8.6

136

M89.0

ICD-10 Finland

Algoneurodystrophy

4.0

8.6

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

8.6

229

A97

ICPC

No disease

1.5

8.6

288

2023

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

8.6

351

Z00.8

ICD-10 Finland

Other general examinations

1.8

8.5

135

787

G25.0

ICD-10 Finland

Essential tremor

2.6

8.5

182

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

8.5

1175

10413

Z01.7

ICD-10 Finland

Laboratory examination

1.5

8.5

241

1631

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

8.5

345

N28

ICPC

Limited function/disability (N)

3.2

8.5

105

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.6

8.5

194

R03AC13

ATC

formoterol; inhalant

2.0

8.5

433

N80

ICPC

Head injury other

2.9

8.5

137

M01AH03

ATC

valdecoxib; oral

2.0

8.5

510

R1260

NOMESCO Finland

Evaluation of communicative skills

3.0

8.5

121

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.9

8.5

132

K04.0

ICD-10 Finland

Pulpitis

1.7

8.4

173

1084

F44.5

ICD-10 Finland

Dissociative convulsions

90.5

8.4

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

8.4

116

649

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

8.4

222

1479

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

2.2

8.4

314

Z50.1

ICD-10 Finland

Other physical therapy

2.0

8.4

435

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

8.4

101

541

RF220, ,

NOMESCO Finland

3.5

8.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

8.4

116

650

P03

ICPC

Feeling depressed

1.7

8.4

174

1094

K56.7

ICD-10 Finland

Ileus, unspecified

3.3

8.4

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.5

8.3

208

K92.0

ICD-10 Finland

Haematemesis

2.7

8.3

167

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

8.3

104

564

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

8.3

507

S06

ICPC

Rash localized

2.0

8.3

472

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.6

8.3

179

G54.0

ICD-10 Finland

Brachial plexus disorders

2.4

8.3

221

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

8.3

895

7642

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.8

8.2

M54

ICD-10 Finland

Dorsalgia

1.6

8.2

210

1388

K92.1

ICD-10 Finland

Melaena

2.1

8.2

404

G50.1

ICD-10 Finland

Atypical facial pain

3.0

8.2

118

R52.0

ICD-10 Finland

Acute pain

2.3

8.2

272

D12

ICPC

Constipation

2.3

8.2

260

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

8.1

133

783

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.8

8.1

146

A07DA03

ATC

loperamide; oral

2.4

8.1

223

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

8.1

301

2155

S12

ICPC

Insect bite/sting

1.8

8.1

126

731

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.7

8.1

152

A05

ICPC

Feeling ill

1.8

8.1

114

642

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.3

8.1

P27

ICPC

Fear of mental disorder

3.3

8.1

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

17.2

8.1

R49.02

ICD-10 Finland

Spasmodic dysphonia

17.2

8.1

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

8.0

566

4530

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.9

8.0

125

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

8.0

212

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

8.0

1618

15174

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

22.1

8.0

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

8.0

465

3609

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

8.0

341

2507

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.1

8.0

354

S06.2

ICD-10 Finland

Diffuse brain injury

3.9

8.0

J01MA14

ATC

moxifloxacin; systemic

1.7

8.0

142

857

SXC05

NOMESCO Finland

Other oral or dental procedure

1.8

8.0

115

653

SPA60

NOMESCO Finland

Fitting of intermediary dental prosthesis structures, 1 to 3 units

3.3

7.9

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.4

7.9

238

G35

ICD-10 Finland

Multiple sclerosis

2.9

7.9

126

RS121, ,

NOMESCO Finland

4.5

7.9

TAC99

NOMESCO Finland

Other blockade for chronic pain

4.5

7.9

S82

ICPC

Naevus/mole

1.6

7.9

213

1426

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

7.9

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.8

7.9

106

589

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.9

7.9

121

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.6

7.9

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

6.1

7.8

E87.5

ICD-10 Finland

Hyperkalaemia

3.1

7.8

100

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.4

7.8

233

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

7.8

496

V19

ICD-10 Finland

Pedal cyclist injured in other and unspecified transport accidents

2.6

7.8

161

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

7.8

123

717

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.1

7.8

324

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

10.8

7.8

N02AC04

ATC

dextropropoxyphene; oral

2.3

7.8

240

D07AC13

ATC

mometasone; topical

1.4

7.8

463

3606

E000001, ,

ATC

1.4

7.8

324

2372

B01AA03

ATC

warfarin; systemic

1.5

7.8

244

1689

R06.2

ICD-10 Finland

Wheezing

2.0

7.7

379

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

7.7

402

3060

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

7.7

644

5280

U04

ICPC

Incontinence urine

2.0

7.7

407

K60.1

ICD-10 Finland

Chronic anal fissure

2.6

7.7

168

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

7.7

440

3403

A46

ICD-10 Finland

Erysipelas

1.5

7.7

213

1434

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

7.7

117

675

N04BD02

ATC

rasagiline; oral

5.9

7.7

M75.8

ICD-10 Finland

Other shoulder lesions

2.1

7.7

333

Z72.2

ICD-10 Finland

Drug use

4.5

7.7

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

7.6

374

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

7.6

142

867

H01

ICPC

Ear pain/earache

1.6

7.6

192

1265

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

4.0

7.6

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

7.6

416

H02.4

ICD-10 Finland

Ptosis of eyelid

2.5

7.6

193

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

11.9

7.6

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.3

7.6

256

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.0

7.6

113

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.3

7.5

231

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.8

7.5

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

7.5

199

1327

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

7.5

142

872

L11

ICPC

Wrist symptom/complaint

1.7

7.5

147

911

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.6

7.5

153

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

2.3

7.5

251

N07CA01

ATC

betahistine; oral

1.8

7.5

108

614

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

7.5

264

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.1

7.4

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.3

7.4

226

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.3

7.4

245

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.4

7.4

ABD40

NOMESCO Finland

Implantation of spinal injection device

80.4

7.4

X14

ICPC

Vaginal discharge

2.7

7.4

148

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.9

7.4

449

SPAT1312

SPAT

General health counselling

1.4

7.4

512

4080

M75.5

ICD-10 Finland

Bursitis of shoulder

2.6

7.4

166

Y96.8

ICD-10 Finland

Other type of accident

4.0

7.3

R83

ICPC

Respiratory infection other

1.4

7.3

439

3417

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.1

7.3

319

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

7.3

181

1188

N87

ICPC

Parkinsonism

3.6

7.3

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

6.9

7.3

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

2.9

7.3

110

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

4.2

7.3

N06AX22

ATC

agomelatine; oral

2.5

7.3

179

N06AA06

ATC

trimipramine; systemic

2.5

7.3

173

XX3XW, ,

NOMESCO Finland

6.3

7.2

J01CA08

ATC

pivmecillinam; oral

1.3

7.2

616

5056

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.4

7.2

204

F44.88

ICD-10 Finland

Other definite dissociation disorder

15.8

7.2

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

7.2

151

951

Y34

ICD-10 Finland

Unspecified event, undetermined intent

4.3

7.2

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.2

7.2

255

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.0

7.2

100

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.3

7.2

217

XKC03

NOMESCO Finland

Water cystometry

2.3

7.2

217

K08.3

ICD-10 Finland

Retained dental root

1.7

7.2

117

689

B01AC04

ATC

clopidogrel; oral

1.5

7.2

223

1540

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

7.2

205

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

7.1

466

3675

F32.8

ICD-10 Finland

Other depressive episodes

2.8

7.1

128

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

7.1

377

Z29

ICPC

Social problem NOS

2.6

7.1

151

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

7.1

121

721

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

7.1

193

IHZ05, ,

SPAT

2.1

7.1

309

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

7.1

112

653

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.9

7.1

117

X57

ICD-10 Finland

Unspecified privation

2.5

7.1

169

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

7.1

263

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

7.1

168

1091

A04AA01

ATC

ondansetron; systemic, rectal

1.7

7.1

121

722

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.3

7.1

231

F27

ICPC

Fear of eye disease

3.8

7.1

C08CA05

ATC

nifedipine; systemic

1.9

7.1

470

N05AB04

ATC

prochlorperazine; systemic, rectal

2.8

7.1

123

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

7.0

108

625

R31

ICD-10 Finland

Unspecified haematuria

1.6

7.0

146

918

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

7.0

414

N08

ICPC

Abnormal involuntary movements

10.1

7.0

N02AJ13

ATC

tramadol and paracetamol; systemic

2.5

7.0

164

H81.4

ICD-10 Finland

Vertigo of central origin

4.2

7.0

N05AL01

ATC

sulpiride; systemic

3.2

7.0

SPAT1310

SPAT

Counselling related to known health issue

1.3

7.0

503

4025

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

7.0

102

582

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

3.0

7.0

102

G72.8

ICD-10 Finland

Other specified myopathies

2.9

7.0

113

ZY000

NOMESCO Finland

Hospital inpatient

2.9

7.0

113

M01AX01

ATC

nabumetone; oral

2.1

7.0

312

EB1VA, ,

NOMESCO Finland

1.5

6.9

197

1334

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

6.9

113

666

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

3.7

6.9

T51.0

ICD-10 Finland

Toxic effect: Ethanol

5.9

6.9

A91

ICPC

Abnormal result investigation NOS

1.9

6.9

438

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.9

6.9

108

G44.8

ICD-10 Finland

Other specified headache syndromes

2.9

6.9

108

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.6

6.9

180

1196

K27

ICPC

Fear cardiovascular disease other

4.0

6.9

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.0

6.9

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

6.9

496

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

13.8

6.9

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

6.9

260

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

6.9

184

EAV, ,

NOMESCO Finland

2.8

6.9

125

XA420

NOMESCO Finland

Extensive sleep examination

3.6

6.9

F01

ICPC

Eye pain

2.3

6.9

228

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.9

6.9

103

SPAT1097

SPAT

Recording of ECG

1.5

6.9

207

1420

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.5

6.8

S70.0

ICD-10 Finland

Contusion of hip

2.1

6.8

294

R03AK11

ATC

formoterol and fluticasone; inhalant

2.4

6.8

191

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

6.7

6.8

AA5PD

NOMESCO Finland

CT examination of brain pefusion

3.8

6.8

B07.9

ICD-10 Finland

Verruca simplex

2.1

6.8

308

C10AC01

ATC

colestyramine; oral

2.4

6.8

185

K04

ICPC

Palpitations/awareness of heart

1.9

6.8

441

G04BD12

ATC

mirabegron; oral

1.6

6.8

164

1071

R5110, ,

SPAT

1.8

6.8

543

R03BB01

ATC

ipratropium bromide; inhalant

2.2

6.8

262

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.8

6.8

115

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.3

6.8

N05AN01

ATC

lithium; oral

2.4

6.7

192

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.6

6.7

144

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.9

6.7

464

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

6.7

224

1569

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.4

6.7

174

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.6

6.7

150

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

7.2

6.7

N04BD01

ATC

selegiline; oral

3.4

6.7

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.5

6.7

156

NG1AD

NOMESCO Finland

Knee CT examination

2.8

6.7

110

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.7

118

711

SPAT1167

SPAT

Insertion of urinary catheter

2.3

6.7

199

U07

ICPC

Urine symptom/complaint other

1.8

6.7

106

620

G24

ICD-10 Finland

Dystonia

22.6

6.7

DQD34

NOMESCO Finland

Treatment of spasmodic dysfonia

22.6

6.7

A02BC04

ATC

rabeprazole; oral

1.6

6.7

141

891

G04BD08

ATC

solifenacin; oral

1.8

6.7

553

N06AX05

ATC

trazodone; oral

2.4

6.7

193

L84

ICPC

Back syndrome without radiat pain

1.9

6.7

422

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.7

6.7

133

AN1

Coronary angiography

1.6

6.7

148

947

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

6.6

163

1068

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

6.6

1179

10627

X78

ICD-10 Finland

Intentional self-harm by sharp object

4.0

6.6

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.5

6.6

151

NH1AD

NOMESCO Finland

Ankle and foot CT

2.5

6.6

163

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

6.6

298

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.7

6.6

128

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.2

6.6

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.2

6.6

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

3.5

6.6

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

6.6

296

2194

R4120, ,

SPAT

4.2

6.6

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

6.5

259

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.8

6.5

SPAT1255

SPAT

Intravenous administration of medicine

1.8

6.5

100

579

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

10.1

6.5

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.1

6.5

266

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

6.5

476

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

6.5

135

849

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

6.9

6.5

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.0

6.5

R41.3

ICD-10 Finland

Other amnesia

2.4

6.5

189

C10AA07

ATC

rosuvastatin; oral

1.3

6.5

456

3630

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

6.5

258

1869

JN4BD

NOMESCO Finland

Extensive body CT

1.6

6.5

151

977

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.6

6.5

141

T74.1

ICD-10 Finland

Physical abuse

2.6

6.5

141

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

6.4

485

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

6.4

148

955

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.4

6.4

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

6.4

385

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

6.4

378

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

6.4

214

1499

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

6.4

380

2950

E000002, ,

ATC

1.5

6.4

173

1160

D95

ICPC

Anal fissure/perianal abscess

3.8

6.4

K80

ICPC

Cardiac arrhythmia NOS

1.7

6.4

115

698

J01MA01

ATC

ofloxacin; systemic

1.7

6.4

119

729

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.1

6.4

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

6.4

282

2084

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.2

6.3

223

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

6.6

6.3

U05

ICPC

Urination problems other

1.9

6.3

408

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.9

6.3

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.9

6.3

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

5.2

6.3

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.2

6.3

230

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

6.3

338

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.2

6.3

S16

ICPC

Bruise/contusion

2.3

6.3

211

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.7

6.3

107

639

N06

ICPC

Sensation disturbance other

3.3

6.3

Z04

ICD-10 Finland

Examination and observation for other reasons

3.0

6.3

S09

ICPC

Infected finger/toe

2.1

6.3

257

R07.1

ICD-10 Finland

Chest pain on breathing

2.8

6.3

103

QDB00

NOMESCO Finland

Suture of skin of lower limb

3.9

6.3

A03FA02

ATC

cisapride; oral, rectal

1.7

6.3

104

617

R07

ICPC

Sneezing/nasal congestion

1.7

6.2

111

671

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

6.2

108

648

K11.2

ICD-10 Finland

Sialoadenitis

2.2

6.2

238

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

6.2

104

618

S61.8

ICD-10 Finland

Open wound of other parts of wrist and hand

2.3

6.2

193

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.2

440

3504

G83.4

ICD-10 Finland

Cauda equina syndrome

7.0

6.2

X84

ICD-10 Finland

Intentional self-harm by unspecified means

7.0

6.2

NA1BG, ,

SPAT

2.6

6.2

138

S69.9

ICD-10 Finland

Unspecified injury of wrist and hand

2.6

6.2

138

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.5

6.2

156

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

6.2

245

N06AX18

ATC

reboxetine; oral

3.1

6.2

R81

ICPC

Pneumonia

2.1

6.2

265

A02BX02

ATC

sucralfate; oral

2.1

6.2

265

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.2

6.2

219

S20.2

ICD-10 Finland

Contusion of thorax

1.8

6.2

455

ZXD20

NOMESCO Finland

Day surgery

1.5

6.2

197

1367

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

6.2

383

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.1

6.2

A06AX04

ATC

linaclotide; oral

6.3

6.2

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

3.2

6.2

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.2

6.2

R29

ICPC

Respiratory symptom/complaint other

1.7

6.1

108

651

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.1

416

3292

L95

ICPC

Osteoporosis

2.2

6.1

220

R07.2

ICD-10 Finland

Precordial pain

2.5

6.1

145

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

6.1

363

D01AE15

ATC

terbinafine; topical

1.7

6.1

103

614

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

2.7

6.1

116

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

6.1

106

637

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

12.6

6.1

N06AX12

ATC

bupropion; oral

1.7

6.1

120

746

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

6.1

179

1222

D07AA02

ATC

hydrocortisone; topical

1.5

6.1

224

1600

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.6

6.1

150

985

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.9

6.1

407

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

6.1

180

1231

TKC22

NOMESCO Finland

Catheterisation instruction

2.5

6.0

152

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

6.7

6.0

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

6.0

372

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

6.0

106

639

T82

ICPC

Obesity

2.0

6.0

344

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.4

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1002

4247

3.94

186.52

3.5

2.2

170.06

254.55

u/l

1.62

962

4006

(3012095) Magnesium [Moles/volume] in Serum or Plasma

658

2342

3.80

153.41

3.0

3.7

0.82

mmol/l

0.03

616

2215

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1156

7058

2.68

90.58

7.4

7.0

1.21

mmol/l

0.18

1030

6014

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1081

6414

2.63

89.43

6.9

6.4

1.21

mmol/l

0.11

1011

5882

(3018418) pH of Serum or Plasma

770

4136

2.47

75.04

4.7

3.9

7.40

0.05

115

822

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

642

3400

2.35

62.13

2.1

1.8

0.86

1.12

mg/l

2.21

497

2576

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

923

5709

2.22

61.13

2.3

1.9

98.98

95.23

pmol/l

1.38

487

3044

(3013826) Glucose [Moles/volume] in Serum or Plasma

1245

8689

2.30

61.12

6.2

5.0

6.48

6.65

mmol/l

2.38

1188

8095

(3024561) Albumin [Mass/volume] in Serum or Plasma

965

6146

2.18

58.53

4.6

4.9

36.14

35.85

g/l

0.83

913

5758

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1116

7633

2.15

54.98

7.1

6.1

10.20

11.75

umol/l

4.54

1073

7254

(3013707) Erythrocyte sedimentation rate by Westergren method

1447

11123

2.35

51.13

5.0

3.9

10.09

11.30

mm/h

3.53

1371

10336

(3015377) Calcium [Moles/volume] in Serum or Plasma

792

4857

2.10

50.88

2.9

3.3

2.34

2.35

mmol/l

2.55

702

4341

(3031040) Bacteria [#/volume] in Urine by Automated count

1327

9860

2.20

50.79

6.3

4.2

71.63

1843.51

e6/l

1.79

136

(3001604) Monocytes [#/volume] in Blood

1100

7641

2.07

49.97

7.6

5.8

0.58

0.57

e9/l

0.51

971

6660

(3006315) Basophils [#/volume] in Blood

1101

7653

2.07

49.90

7.6

5.8

0.04

e9/l

0.34

974

6670

(3003458) Phosphate [Moles/volume] in Serum or Plasma

407

1917

2.44

49.87

4.4

6.2

1.03

1.04

mmol/l

0.13

386

1782

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

758

4603

2.09

49.70

3.6

2.5

57.88

76.27

u/l

0.53

701

4278

(3022217) INR in Platelet poor plasma by Coagulation assay

972

6478

2.05

49.23

14.0

13.9

1.18

1.23

inr

0.94

272

1977

(3013115) Eosinophils [#/volume] in Blood

1122

7908

2.05

48.25

7.9

6.1

0.20

0.19

e9/l

0.98

1015

6986

(3019198) Lymphocytes [#/volume] in Blood

1117

7890

2.04

47.37

7.6

5.9

1.89

1.96

e9/l

0.88

1011

7037

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

506

2690

2.21

46.26

5.0

3.5

84.62

492.31

ng/l

6.68

349

1977

(3013650) Neutrophils [#/volume] in Blood by Automated count

1204

8823

2.03

44.96

11.1

8.8

4.06

4.08

e9/l

0.15

1069

7736

(3033658) Prothrombin time (PT) actual/Normal

644

3794

2.07

44.79

5.7

4.0

92.38

91.31

0.49

627

3691

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1455

11464

2.23

44.37

9.4

7.3

76.32

77.79

u/l

0.64

1388

10839

(40760892) CBC W Ordered Manual Differential panel - Blood

1033

7211

1.97

43.95

7.5

6.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

826

5360

1.97

43.36

4.9

3.4

28.23

56.15

ng/l

1.69

558

3502

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

262

1066

2.70

43.17

2.4

20.35

24.63

au/ml

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

291

1271

2.53

41.39

5.8

8.3

1.40

1.36

mmol/l

0.14

281

1241

(3021960) Folate [Moles/volume] in Serum or Plasma

565

3249

2.06

41.37

1.7

1.5

19.53

20.59

nmol/l

1.04

491

2786

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

7.01

40.42

1.3

1.5

5.30

8.52

u/l

0.97

(3019069) Monocytes/100 leukocytes in Blood

1020

7214

1.91

40.38

7.8

6.3

8.52

8.48

0.18

975

6779

(3022096) Basophils/100 leukocytes in Blood

990

6937

1.91

40.29

7.6

6.0

0.66

0.67

0.19

942

6496

(3006504) Eosinophils/100 leukocytes in Blood

1015

7172

1.91

40.24

7.5

6.0

2.86

2.83

0.15

970

6731

(3002030) Lymphocytes/100 leukocytes in Blood

1042

7450

1.90

39.58

7.6

6.0

27.94

28.36

0.65

999

7024

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

347

1677

2.31

39.26

3.2

2.9

7.06

8.23

umol/l

0.46

290

1460

(3002582) Erythrocytes [#/volume] in Urine

701

4416

1.94

39.11

4.4

3.2

32.35

95.36

e6/l

2.25

566

3388

(3030467) Casts [#/volume] in Urine by Automated count

655

4040

1.96

38.85

4.3

3.1

0.30

0.42

e6/l

0.82

526

3054

(3018095) Leukocytes [#/volume] in Urine

791

5208

1.90

38.42

5.1

3.6

50.63

97.32

e6/l

0.96

594

3644

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

430

2291

2.14

38.15

2.2

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

458

2500

2.10

38.13

1.8

1.7

1171.60

1172.11

nmol/l

0.00

361

1909

(3000991) Gas panel - Venous blood

275

1232

2.45

36.79

7.0

9.7

—

(3018010) Neutrophils/100 leukocytes in Blood

1019

7339

1.86

36.72

7.4

5.8

56.85

56.89

0.04

974

6914

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

149

484

3.26

36.64

2.1

2.4

126.38

461.50

ug/l

2.40

139

459

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

764

5035

1.88

36.49

3.8

3.2

33.37

32.13

u/l

0.31

726

4796

(3018677) aPTT in Platelet poor plasma by Coagulation assay

419

2250

2.11

36.21

2.7

2.2

29.99

29.83

0.22

412

2174

(36304419) Bacteria [Presence] in Urine

637

3970

1.92

36.06

4.3

3.0

—

(40758558) Short blood count panel - Blood

618

3822

1.92

35.75

7.4

6.6

—

(3000850) Epithelial cells [#/volume] in Urine

523

3076

1.97

34.98

3.2

2.5

5.10

6.10

e6/l

1.15

487

2769

(3037467) Urinalysis macro (dipstick) panel - Urine

1317

10383

1.91

34.64

5.7

4.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

284

1327

2.35

34.44

4.4

4.3

5.93

5.85

kpa

0.63

276

1288

(3020630) Protein [Mass/volume] in Serum or Plasma

249

1102

2.45

34.08

2.6

2.7

66.65

66.61

g/l

0.03

231

1016

(3002032) Base excess in Venous blood by calculation

282

1322

2.34

33.91

4.4

4.3

1.86

1.88

mmol/l

0.03

246

1089

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

188

728

2.76

33.81

4.3

4.8

24.41

24.04

mmol/l

0.85

182

713

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

316

1595

2.18

31.65

2.1

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1432

11775

1.93

30.96

4.9

3.9

14.62

14.66

pmol/l

0.22

1338

10800

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

125

410

3.20

30.19

1.4

804.11

530.55

mg/l

0.52

118

387

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

313

1604

2.14

30.05

2.2

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

859

6111

1.75

30.04

2.7

2.3

76.44

75.87

nmol/l

0.23

793

5541

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

427

2456

1.96

29.83

3.7

2.7

0.90

1.02

e6/l

0.38

252

1378

(3001122) Ferritin [Mass/volume] in Serum or Plasma

947

6934

1.74

29.82

3.4

2.8

113.82

117.00

ug/l

0.20

883

6440

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1733

15406

2.78

29.57

22.8

13.2

19.93

23.14

mg/l

4.60

1472

12088

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

450

2643

1.93

29.50

1.4

1.3

22.46

29.37

iu/ml

0.40

132

869

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

310

1597

2.13

29.31

6.1

8.9

5.09

5.11

kpa

0.11

294

1523

(3027801) Oxygen [Partial pressure] in Arterial blood

310

1598

2.13

29.26

6.1

8.9

11.80

12.36

kpa

1.32

293

1527

(3003396) Base excess in Arterial blood by calculation

309

1591

2.13

29.25

6.1

9.0

0.66

1.03

mmol/l

0.95

257

1255

(3023368) Bacteria identified in Blood by Culture

596

3843

1.81

28.99

5.0

4.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1740

15545

2.79

28.52

24.5

15.0

139.39

139.64

mmol/l

3.65

1718

15143

(3015736) pH of Urine

838

5996

1.72

28.11

4.0

3.2

6.16

5.85

1.90

508

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

113

365

3.23

27.98

1.4

1.5

4.92

36.82

e6/l

1.22

285

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

113

365

3.23

27.98

1.5

1.6

346.80

1824.65

e6/l

0.98

293

(3023103) Potassium [Moles/volume] in Serum or Plasma

1742

15596

2.79

27.97

24.6

15.1

3.95

3.96

mmol/l

1.56

1716

15177

(3037522) Nuclear Ab [Titer] in Serum

373

2090

1.98

27.92

1.4

1.3

562.25

504.07

titre

0.24

427

(3044290) Cell count panel - Cerebral spinal fluid

107

335

3.33

27.87

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

279

1407

2.16

27.77

3.4

2.4

31.80

73.93

u/l

0.66

242

1198

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1620

14074

2.15

27.67

6.1

4.6

1.76

2.18

mu/l

1.80

1540

13004

(3026782) Osmolality of Urine

477

2912

1.86

27.49

3.4

2.8

533.25

544.89

mosm/kgh2o

0.54

429

2512

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

577

3740

1.79

27.26

2.7

2.2

2.87

2.92

mg/l

0.20

489

3187

(3026008) Bacteria identified in Urine by Culture

639

4270

1.76

27.14

3.8

2.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

400

2317

1.92

27.07

3.9

2.9

4.33

2.36

e6/l

2.07

222

1245

(3009466) Valproate [Moles/volume] in Serum or Plasma

238

3.74

27.02

6.3

5.6

375.76

358.31

umol/l

0.49

208

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

578

3760

1.78

26.90

3.0

3.1

991.10

1307.17

ng/l

1.24

482

3184

(3024354) Oxygen [Partial pressure] in Venous blood

234

1116

2.25

26.70

3.7

3.6

4.60

4.66

kpa

0.17

224

1080

(3004588) Protein electrophoresis panel - Serum or Plasma

203

911

2.38

26.69

2.5

2.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

276

1418

2.11

26.09

2.2

2.1

341.36

371.54

nmol/l

1.82

258

1315

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

108

364

3.09

24.89

1.4

1.3

3.68

3.79

mmol/l

0.62

100

344

(3028707) Methadone [Presence] in Urine by Screen method

100

323

3.21

24.76

3.7

2.9

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

170

736

2.44

24.15

6.6

11.7

24.35

24.32

mmol/l

0.04

161

717

(3022948) Iron [Moles/volume] in Serum or Plasma

381

2255

1.87

23.81

2.6

2.5

13.22

13.59

umol/l

0.46

357

2104

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

359

2087

1.89

23.72

2.5

1.8

1.60

1.46

1.74

318

1855

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

419

2559

1.82

23.65

2.7

2.9

2.42

2.44

mmol/l

2.38

363

2260

(3021589) Normoblasts [#/volume] in Blood

905

6817

1.64

23.49

10.9

9.2

0.00

e9/l

0.05

727

5600

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

117

427

2.86

23.41

2.6

1.08

1.06

g/l

0.02

102

383

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

541

3576

1.72

23.17

1.4

1.3

1.32

1.51

u/ml

0.17

135

961

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

124

470

2.76

23.11

2.5

2.4

2.79

2.90

g/l

0.69

112

432

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

215

1054

2.18

22.79

3.6

4.3

89.47

86.55

ng/l

0.16

186

941

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

498

2.69

22.67

2.4

3.56

3.66

g/l

0.43

116

460

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

498

2.69

22.67

2.4

7.09

7.28

g/l

0.67

116

460

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

498

2.69

22.67

2.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1277

10544

1.67

22.49

4.8

3.1

56.15

46.97

u/l

1.84

1208

9941

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

183

846

2.29

22.37

1.7

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

207

1007

2.19

22.36

1.7

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

963

7431

1.61

22.17

4.4

3.5

0.00

estimate

1.23

168

1520

(3004789) Transferrin [Mass/volume] in Serum or Plasma

351

2074

1.85

21.87

2.6

2.5

2.35

2.34

g/l

0.02

328

1925

(3021601) Nitrite [Presence] in Urine by Test strip

960

7422

1.61

21.77

5.8

4.7

0.00

estimate

0.50

164

1448

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

108

393

2.86

21.73

2.4

2.3

38.74

37.74

g/l

0.93

355

(3023410) Appearance of Cerebral spinal fluid

177

3.83

21.71

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

175

805

2.30

21.63

2.1

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

463

2.70

21.60

2.5

2.4

9.84

10.49

g/l

0.92

108

424

(3009261) Glucose [Presence] in Urine by Test strip

966

7490

1.60

21.56

4.4

3.5

0.00

estimate

0.80

163

1382

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

105

4.77

21.55

1.1

0.13

3.01

nmol/l

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

130

4.33

21.44

1.1

1.2

39.91

38.92

mg/l

0.06

104

(3016502) Oxygen saturation in Arterial blood

263

1426

1.98

21.21

6.5

9.5

95.15

95.71

0.60

258

1374

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

105

383

2.85

21.03

2.4

0.02

g/l

0.07

358

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

100

360

2.88

20.52

2.4

0.01

0.00

g/l

0.71

336

(3011397) Hemoglobin [Presence] in Urine by Test strip

507

3392

1.68

20.31

4.1

3.4

—

(3036180) Methadone [Presence] in Urine

5.51

20.28

2.8

2.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

357

2.87

20.25

2.4

0.00

g/l

-0.00

335

(3044640) Blood type and Crossmatch panel - Blood

665

4769

1.61

20.20

2.9

2.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

169

3.76

19.94

1.1

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

478

3163

1.69

19.90

1.8

1.5

2.25

2.35

g/l

0.48

275

1985

(3044889) 12 lead EKG panel

1246

10385

1.60

19.55

4.1

3.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

331

2.90

19.49

4.3

3.3

30.49

35.05

umol/l

1.49

301

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

183

897

2.15

19.32

7.1

10.7

0.68

0.02

178

889

(3048689) Calprotectin [Mass/mass] in Stool

322

1934

1.80

18.79

2.2

2.4

132.71

117.48

ug/g

0.31

259

1534

(40768797) Stomach Pathology biopsy report

337

2057

1.78

18.61

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

128

4.07

18.40

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

170

3.61

18.26

1.7

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

107

426

2.60

18.10

2.8

3.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

318

1923

1.79

18.09

2.8

2.6

22.67

23.58

0.57

283

1656

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

917

7206

1.54

18.03

3.0

2.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

179

903

2.09

17.51

6.9

10.6

1.30

1.36

0.40

174

896

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

186

953

2.06

17.45

3.1

3.4

4.45

4.55

pmol/l

0.73

169

847

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

5.69

17.29

3.1

2.9

25.92

30.69

umol/l

1.41

(3007853) Bacteria identified in Skin by Aerobe culture

297

1785

1.79

17.19

2.1

1.7

—

(3025941) Bacteria identified in Stool by Culture

170

848

2.11

17.12

1.3

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

230

1280

1.91

17.01

6.0

8.3

8.70

9.10

mmol/l

0.38

219

1224

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

105

4.27

16.98

1.6

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

5.23

16.77

3.3

3.5

188.32

126.38

umol/l

0.57

(1001926) Buprenorphine [Presence] in Urine by Screen method

127

571

2.31

16.52

3.4

2.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

217

1200

1.91

16.34

2.9

2.7

9.84

10.46

g/l

1.56

198

1104

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

210

1157

1.92

15.98

2.9

2.4

4.99

6.87

ug/l

0.93

173

1042

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

440

3028

1.59

15.08

1.7

463.31

25471379.64

pmol/l

2.71

381

2548

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

380

2526

1.63

15.02

1.4

1.3

3.42

10.59

u/ml

4.70

139

1013

(40761511) CBC panel - Blood by Automated count

1738

16167

2.11

14.96

19.6

12.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

511

3649

1.55

14.88

2.9

2.3

—

(3016879) Cocaine [Presence] in Urine

138

673

2.13

14.72

3.7

2.2

—

(3019150) Specific gravity of Urine by Refractometry

464

3256

1.57

14.55

4.7

3.7

1.02

kg/l

0.12

455

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

190

1052

1.90

14.21

2.7

2.9

158.98

181.37

ng/l

0.36

165

959

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

148

754

2.05

14.07

8.4

12.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1582

14355

1.67

14.02

19.2

12.0

85.99

84.61

ml/min/173m2

1.61

1396

11820

(3011288) Drugs identified in Urine by Screen method

112

513

2.26

13.96

4.8

2.9

—

(3042936) Bacteria identified in Isolate by Culture

327

2132

1.65

13.86

2.3

2.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

426

2.37

13.78

1.6

1.5

267.22

283.89

ug/g

0.34

242

(3000764) Benzodiazepines [Presence] in Urine

143

725

2.05

13.77

3.7

2.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

527

3849

1.51

13.63

2.9

2.6

2619.94

5394.68

umol/l

1.14

454

3397

(40768804) Tissue Pathology biopsy report

767

6047

1.46

13.47

2.3

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

175

960

1.91

13.45

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

143

733

2.03

13.37

3.8

2.1

—

(36660697) Celiac disease serology panel - Serum

216

1271

1.79

13.27

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

100

447

2.31

13.21

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

317

2.56

13.20

2.2

3.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

378

2.42

13.19

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

142

730

2.02

13.17

3.7

2.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

100

448

2.30

13.14

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

385

2.41

13.13

1.6

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1599

14627

1.66

12.79

5.0

4.2

5.94

5.89

mmol/l

0.77

1494

13437

(42529406) Shigella sp [Presence] in Stool by Culture

100

454

2.27

12.74

1.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

139

720

2.01

12.62

3.8

2.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

184

1048

1.84

12.57

1.4

1.3

146.71

213.96

u/ml

1.30

172

967

(3009508) Creatinine [Moles/volume] in Urine

594

4514

1.46

12.39

3.8

3.3

7.71

7.89

mmol/l

0.40

517

3861

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1515

13730

1.55

12.07

6.3

5.3

39.30

39.39

mmol/mol

0.14

1427

12811

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

4.96

11.69

1.5

1.3

165.96

126.99

nmol/l

0.35

(3002385) Erythrocyte distribution width [Ratio]

1492

13513

1.52

11.55

26.2

15.7

14.75

14.70

0.11

1472

13270

(3027945) Reticulocytes/100 erythrocytes in Blood

247

1571

1.66

11.41

2.9

2.8

1.80

1.78

0.11

211

1403

(3021387) Prolactin [Units/volume] in Serum or Plasma

127

662

1.99

11.34

1.6

366.28

300.23

mu/l

0.99

119

596

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

220

1363

1.70

11.22

3.2

2.4

0.23

0.22

g/l

1.70

212

1276

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

162

920

1.83

11.16

3.9

4.6

1.63

1.62

mmol/l

0.01

117

696

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

167

962

1.81

10.98

4.0

4.6

5.21

5.15

kpa

0.45

161

922

(3009343) pH of Capillary blood

165

956

1.80

10.65

3.9

4.6

7.40

7.41

0.01

113

(3006653) Thiamine [Moles/volume] in Blood

3.77

10.60

1.1

1.4

147.62

144.31

nmol/l

0.10

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

102

3.48

10.31

1.0

1.1

0.99

1.06

u/l

0.45

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

425

3135

1.46

10.00

1.9

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

111

578

1.98

9.96

1.2

0.26

1.12

u/ml

1.01

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1730

16356

1.80

9.88

14.4

9.8

28.06

26.73

u/l

1.87

1695

15845

(3028026) IgM [Mass/volume] in Serum or Plasma

161

952

1.76

9.69

2.3

1.8

1.58

1.41

g/l

0.21

144

880

(3003327) Ova and parasites identified in Stool by Light microscopy

100

509

2.02

9.57

1.7

1.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

183

2.72

9.51

1.5

1.6

—

(3036489) Thrombin time

112

598

1.93

9.36

2.6

2.5

20.52

21.59

1.63

526

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

708

5775

1.36

9.17

4.6

3.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

237

1577

1.58

9.04

3.5

4.1

224.09

243.22

u/l

1.78

223

1492

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

160

2.79

9.00

1.4

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

507

1.98

8.98

1.7

1.5

200.00

141.25

titre

—

(3019060) Gas panel - Arterial blood

151

898

1.74

8.92

4.6

5.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1206

10698

1.36

8.90

4.0

3.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

113

3.14

8.81

2.5

2.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

519

1.96

8.74

2.6

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

297

2.27

8.67

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

297

2.27

8.67

1.5

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

514

1.96

8.64

1.4

10.13

8.49

u/l

0.73

420

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

123

700

1.81

8.44

2.3

—

(3013512) EKG study

518

4063

1.38

8.42

4.5

3.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

124

2.94

8.14

2.4

1.4

1.62

1.15

promille

0.77

(40761535) Cells panel - Urine sediment

184

1182

1.62

8.12

4.2

3.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

152

2.74

8.11

1.4

5.87

7.17

g/l

1.74

107

(3028192) IgG subclass 2 [Mass/volume] in Serum

152

2.74

8.11

1.4

2.60

3.00

g/l

0.81

105

(3024139) IgG subclass 3 [Mass/volume] in Serum

152

2.74

8.11

1.4

0.37

0.41

g/l

0.25

105

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.23

7.95

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.33

7.80

1.1

—

(3022145) Colonoscopy Study observation

241

1663

1.52

7.77

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

114

651

1.80

7.75

1.1

—

0.89

—

(4062490) Immunoglobulin typing, IgG

156

2.66

7.73

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

484

1.93

7.73

1.8

1.6

1.20

1.18

g/l

0.16

455

(3003181) Sodium [Moles/volume] in Urine

229

2.35

7.68

1.6

1.4

59.49

65.49

mmol/l

0.63

193

(3000492) Spirometry study

228

1563

1.52

7.58

1.5

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

342

2.09

7.54

1.5

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

499

3955

1.36

7.45

1.8

1.6

1.51

1.39

mmol/l

1.50

441

3341

(3000494) Fungus identified in Specimen by Culture

254

1789

1.49

7.41

1.6

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

143

885

1.67

7.32

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

119

701

1.75

7.30

3.2

2.2

3421.91

4975.54

u/l

0.32

279

(3034860) Kappa light chains.free [Mass/volume] in Serum

402

1.98

7.27

3.7

3.6

60.60

65.86

mg/l

0.08

325

(4200892) Spirometry reversibility

159

1015

1.62

7.21

1.5

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

321

2.09

7.21

1.4

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

404

1.97

7.18

3.8

3.5

56.15

40.84

mg/l

0.25

328

(3023323) Follitropin [Units/volume] in Serum or Plasma

129

782

1.70

7.14

1.4

26.15

26.63

iu/l

0.06

116

662

(3023520) Reticulocytes [#/volume] in Blood

174

1139

1.58

7.11

2.1

2.8

72.92

71.67

e9/l

0.15

125

864

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

392

1.98

7.08

3.8

3.5

1.33

1.64

ratio

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

470

1.89

7.08

1.9

1.6

0.24

g/l

0.03

444

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

266

2.18

6.92

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

273

1977

1.45

6.89

1.7

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

499

4002

1.34

6.80

5.2

3.8

0.00

0.01

estimate

1.28

163

1395

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.16

6.72

1.5

1.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

270

2.15

6.68

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

3.73

6.64

1.5

2.2

210.71

253.45

e6/l

0.27

(3023419) Bacteria identified in Sputum by Culture

213

2.29

6.59

3.6

2.8

—

(3012501) Base excess in Blood by calculation

313

2.05

6.53

3.6

4.1

2.78

2.34

mmol/l

0.36

204

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

2.90

6.48

1.8

1.5

—

(40768443) Skin Pathology biopsy report

102

596

1.75

6.46

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

255

2.15

6.39

1.7

0.82

0.86

g/l

0.09

199

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.08

6.36

1.2

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

132

831

1.63

6.35

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

532

1.79

6.34

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.47

6.29

1.7

2.6

—

(1616796) Gas panel - Central venous blood

305

2.03

6.23

3.0

3.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

168

1127

1.54

6.18

1.3

1.2

183.11

153.36

iu/ml

0.31

437

(21494815) CD4 cells/100 lymphocytes in Specimen

140

2.53

6.04

2.6

2.2

44.34

39.06

1.42

140

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

518

1.77

6.02

2.1

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

449

1.82

5.83

1.4

1.3

—

(3022313) Gas panel - Capillary blood

115

716

1.65

5.80

4.3

4.9

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

11.16

5.79

1.0

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

570

1.72

5.78

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

466

1.79

5.74

3.0

187.74

180.93

0.25

445

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

572

1.72

5.71

2.3

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

288

2.01

5.69

1.6

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

178

1234

1.49

5.61

2.7

2.2

12.02

12.86

nmol/l

0.68

163

1116

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

249

2.08

5.58

1.1

3.10

143.10

iu/ml

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

122

2.57

5.55

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

122

2.57

5.55

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

122

2.57

5.55

1.2

1.1

—

(3007461) Platelets [#/volume] in Blood

1783

17285

1.73

5.52

32.8

19.3

252.33

252.27

e9/l

0.01

1759

16876

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

285

1.99

5.49

1.6

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

123

2.55

5.46

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

123

2.55

5.46

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

123

2.55

5.46

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

180

1258

1.48

5.46

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

100

612

1.67

5.40

1.6

1.9

1.47

1.50

g/l

0.12

531

(3047181) Lactate [Moles/volume] in Blood

439

1.79

5.35

5.4

8.3

1.41

1.28

mmol/l

0.48

379

(3024731) MCV [Entitic volume]

1783

17298

1.71

5.32

32.7

19.2

90.83

90.68

0.66

1773

17080

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

463

1.76

5.29

3.0

2.8

—

(21494755) Public health laboratory ask at order entry panel

112

1713

0.63

5.28

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

1783

17301

1.70

5.28

32.8

19.3

4.49

4.52

e12/l

1.87

1758

16865

(3010813) Leukocytes [#/volume] in Blood

1783

17301

1.70

5.28

32.9

19.3

6.82

6.72

e9/l

1.37

1757

16860

(3009542) Hematocrit [Volume Fraction] of Blood

1781

17278

1.69

5.26

32.9

19.4

40.16

40.62

0.86

1697

16283

(46235355) HIV 1 and 2 tests - Meaningful Use set

414

3343

1.31

5.21

2.0

1.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

1783

17308

1.69

5.17

33.0

19.4

135.30

136.10

g/l

1.55

1772

17085

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

267

2024

1.37

5.15

2.1

2.0

—

(3035941) MCH [Entitic mass]

1782

17299

1.68

5.13

32.7

19.2

30.32

30.25

0.91

1773

17079

(3020891) Body temperature

552

1.68

5.10

5.8

4.9

—

(3003338) MCHC [Mass/volume]

1431

13401

1.29

5.09

28.9

16.6

333.40

332.89

g/l

1.39

1426

13307

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

147

2.34

5.02

1.1

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

117

2.50

4.96

1.9

1.4

72.97

78.80

umol/l

0.63

117

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

180

2.19

4.95

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

106

674

1.61

4.95

1.6

2.0

37.51

38.75

u/l

0.28

100

601

(3045414) Leukocytes [Presence] in Urine

103

651

1.62

4.93

2.0

1.8

—

(3019225) pH of Specimen

192

1387

1.43

4.90

4.6

4.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

106

2.57

4.89

2.5

1.9

—

(3051651) Icteric interference index of Serum or Plasma

2.72

4.85

3.3

3.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

584

1.64

4.82

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

379

1.80

4.81

1.3

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

295

1.89

4.68

3.6

3.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.60

4.64

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.12

4.64

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

287

2236

1.34

4.62

2.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

437

1.72

4.60

1.1

—

(3042517) Benzodiazepines panel - Urine

6.14

4.60

2.3

2.0

—

(3012516) Albumin [Mass/volume] in Urine

487

4073

1.26

4.58

3.8

3.3

657.82

277.45

mg/l

0.75

339

2674

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

164

1168

1.44

4.54

2.7

2.6

77.02

68.40

ml/min/173m2

1.77

459

(3051611) Lipemic interference index of Serum or Plasma

135

2.32

4.53

3.0

3.2

—

(3002256) Pathology report gross observation

249

1909

1.35

4.46

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

130

2.33

4.44

1.6

1.5

12.20

12.75

umol/l

0.20

123

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

2.70

4.42

1.1

1.4

—

71.85

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

7.53

4.35

1.0

1.4

4.33

15.25

u/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.35

4.32

1.3

1.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

2.60

4.31

2.3

2.8

39478.26

40717.39

ug/l

0.17

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

101

2.50

4.30

1.4

2.0

—

(3037756) Immunofixation for Serum or Plasma

290

1.85

4.27

1.9

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

494

1.65

4.24

1.4

1.6

0.06

13.41

iu/ml

0.50

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.57

4.22

3.5

3.4

89.91

98.13

0.58

(1761868) Lipid panel - Serum or Plasma

489

5723

0.80

4.16

2.9

2.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

337

1.78

4.15

1.4

1.7

17951.17

12768.54

e6/l

0.34

249

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.26

4.14

1.1

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.91

4.13

1.1

1.2

—

(3011985) Renin [Units/volume] in Plasma

168

2.10

4.08

1.6

1.4

111.06

39.84

mu/l

0.39

152

(3049717) Cytology report of Urine Cyto stain

523

1.61

4.07

2.4

2.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

129

2.27

4.07

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

129

2.27

4.07

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

129

2.27

4.07

1.4

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

169

1236

1.40

4.05

4.2

4.1

0.96

1.01

0.10

412

(3020682) Albumin/Creatinine [Ratio] in Urine

504

4285

1.24

4.04

4.2

3.9

6.77

9.26

mg/mmol

0.91

332

2761

(3020123) Porphyrins [Interpretation] in Serum or Plasma

10.03

4.01

1.1

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.91

3.99

1.9

2.1

13.72

17.99

umol/l

0.77

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

338

2747

1.28

3.97

1.7

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

124

2.28

3.97

1.6

1.3

0.64

1.06

u/ml

0.31

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

2.55

3.97

1.1

1.0

317.31

270.64

ng/l

0.19

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.14

3.93

1.1

1.4

77.14

92.32

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.14

3.93

1.1

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.14

3.93

1.1

1.0

80.00

91.92

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.27

3.91

2.1

2.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

185

2.02

3.89

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

2.52

3.88

1.1

1.0

903.20

650.74

ng/l

1.42

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

2.52

3.88

1.1

1.0

44.09

43.85

ng/l

0.01

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

200

1516

1.36

3.87

4.0

3.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

249

1.87

3.86

2.1

2.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

171

1266

1.39

3.83

1.9

2.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

446

1.64

3.80

3.6

3.4

0.39

0.35

u/ml

0.32

246

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

439

1.64

3.78

2.0

1.7

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

8.78

3.77

1.0

1.4

295.57

661.13

u/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

181

2.01

3.74

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.93

3.74

3.6

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

115

2.28

3.71

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

289

1.79

3.71

2.3

2.5

16.66

16.35

0.14

148

(3024891) Influenza virus A+B Ag [Presence] in Specimen

449

1.63

3.71

1.3

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1515

14450

1.26

3.66

4.3

3.8

1.39

1.29

mmol/l

4.10

1428

13380

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

116

2.26

3.65

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

176

2.01

3.64

1.3

—

nmol/l

—

(3022621) pH of Urine by Test strip

133

953

1.43

3.60

3.0

2.7

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

3.52

3.60

1.0

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.02

3.59

1.2

1.1

67.40

79.29

—

(3021440) Promyelocytes/100 leukocytes in Blood

159

1178

1.38

3.56

4.3

4.2

0.13

0.11

354

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1592

15289

1.28

3.53

5.4

4.6

2.78

mmol/l

0.06

1503

14221

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

157

1164

1.38

3.50

3.9

3.5

1.22

1.23

mmol/l

1.75

139

1008

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.63

3.49

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.71

3.49

2.7

2.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.89

3.49

1.1

68.60

88.88

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

569

1.54

3.47

1.5

1.3

225.60

226.77

miu/ml

0.01

270

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

138

1004

1.40

3.44

1.7

1.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

514

1.56

3.44

2.0

1.8

43.79

38.97

nmol/l

0.94

496

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.36

3.41

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.36

3.41

1.1

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

335

1.69

3.40

1.3

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

238

1.83

3.40

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.09

3.39

1.4

1.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

3.77

3.39

1.2

1.1

104.00

107.78

0.16

(3030905) Polymorphonuclear cells [#/volume] in Blood

313

1.71

3.38

3.7

3.4

4.13

4.18

e9/l

0.07

313

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

239

1.82

3.36

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

368

1.65

3.33

2.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

240

1.81

3.32

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

479

1.57

3.30

1.8

—

(3017732) Neutrophils [#/volume] in Blood

143

1055

1.38

3.30

3.5

2.9

4.03

5.70

e9/l

1.70

118

884

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

183

1.93

3.30

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

183

1.93

3.30

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.95

3.29

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

111

1541

0.70

3.26

1.9

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

184

1.92

3.25

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

218

1718

1.30

3.25

7.8

6.7

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

264

1.76

3.25

1.5

2.1

—

4.80

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

325

1.68

3.23

3.7

57.87

57.00

0.22

325

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

535

4668

1.20

3.22

4.7

1.90

2.52

ug/l

1.71

486

4189

(3041096) Erythrocytes [Presence] in Urine by Automated

481

4155

1.21

3.22

4.1

3.1

—

(3021788) Differential panel - Synovial fluid

265

1.75

3.21

1.4

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

185

1.91

3.20

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

243

1.79

3.20

2.5

1.3

—

(3025159) Blasts/100 leukocytes in Blood

149

1113

1.37

3.19

4.4

4.2

0.19

0.41

0.32

291

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.87

3.19

1.1

101.50

118.91

0.97

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.35

3.19

1.1

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

222

1.82

3.16

1.8

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

208

1.84

3.14

1.5

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

4.02

3.08

1.8

2.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1049

0.65

3.08

1.6

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.19

3.05

3.9

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.59

3.04

1.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

133

2.05

3.02

2.6

2.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

363

1.62

3.00

1.4

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

161

1.94

3.00

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

433

3727

1.21

2.99

4.0

4.1

20.29

21.38

0.75

193

1713

(3011648) Oxygen content in Venous blood

127

2.06

2.97

2.4

4.1

12.03

11.07

0.61

127

(3008295) Osmolality of Serum or Plasma

162

1.93

2.95

1.5

1.6

282.05

281.85

mosm/kgh2o

0.01

123

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

414

1.57

2.90

1.7

2.1

12.86

11.12

mg/l

0.96

382

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

266

1.71

2.90

1.3

1.5

0.23

0.34

nmol/l

1.23

210

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

337

1.62

2.85

1.1

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

2.30

2.84

1.1

1.3

—

971.25

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

253

1.72

2.82

1.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

253

1.72

2.82

1.4

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1563

15062

1.23

2.82

4.9

4.2

4.66

4.67

mmol/l

0.13

1480

14114

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.41

2.80

1.6

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.41

2.80

1.6

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

224

1.76

2.79

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

239

1.73

2.79

1.7

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.21

2.74

1.3

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

429

1.53

2.72

1.1

1.2

52.00

93.90

titre

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.16

2.64

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.66

2.62

1.1

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

259

1.68

2.62

1.4

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

200

1.76

2.57

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

403

1.53

2.56

1.6

1.9

2.34

5.23

iu/l

3.56

138

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.16

2.55

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

356

1.56

2.53

1.4

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

146

1130

1.32

2.52

4.1

3.9

0.73

0.65

0.15

354

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1551

14976

1.21

2.50

4.8

4.1

1.41

1.45

mmol/l

3.11

1467

13936

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.39

2.47

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

319

1.58

2.45

1.3

1.2

8.56

39.12

u/ml

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

152

1.85

2.43

3.5

4.9

93.88

43.65

u/ml

0.37

(4094501) Cardiovascular stress test using bicycle ergometer

392

1.52

2.43

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.30

2.41

1.4

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.30

2.41

1.4

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.01

2.40

1.0

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.35

2.39

2.7

2.0

123.60

144.41

nmol/l

0.46

(3010144) Erythrocytes [#/volume] in Synovial fluid

139

1.88

2.37

1.3

36158.63

85549.24

e6/l

0.42

(3036670) Protein [Mass/volume] in Synovial fluid

2.83

2.34

1.1

1.2

38.80

37.28

g/l

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.10

2.33

5.1

7.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

340

1.54

2.31

1.3

1.5

—

12.84

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

309

1.57

2.28

1.9

2.3

133.47

130.61

g/l

0.33

229

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

390

1.50

2.27

1.2

3.10

10.01

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.63

2.27

1.0

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

172

1.76

2.21

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

233

1.64

2.21

1.3

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

2.42

2.20

1.1

14.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.34

2.18

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

444

1.46

2.17

1.1

10.70

4.58

u/ml

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

108

1.96

2.15

1.0

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.30

2.15

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.30

2.14

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.30

2.14

1.5

1.4

—

(3044007) Cell count panel - Peritoneal fluid

2.63

2.14

2.7

2.1

—

(1002224) Polysomnography panel

700

1.36

2.14

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.37

2.12

3.2

3.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.46

2.10

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.21

2.09

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

3.21

2.09

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

131

1.84

2.08

1.3

1.2

90.00

200.00

titre

—

(3014271) Vancomycin [Susceptibility]

2.27

2.07

2.4

2.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.27

2.07

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.27

2.07

1.4

1.0

—

(3025130) Human papilloma virus identified in Specimen

214

1.65

2.07

1.5

1.9

—

(4212803) Bone marrow aspirate examination

5.01

2.07

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

222

1.63

2.06

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

301

0.49

2.04

1.3

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.01

2.04

1.0

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.01

2.04

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

384

1.47

2.03

1.2

2.96

2.55

u/ml

—

(3035933) Granulocytes/100 leukocytes in Blood

2.41

2.02

1.2

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

112

1.88

1.96

4.4

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.20

1.94

1.1

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.55

1.94

2.0

4.2

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.76

1.93

1.2

1.4

1.41

1.19

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.76

1.93

1.2

1.4

1.72

0.64

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.76

1.93

1.2

1.4

1.00

1.25

mg/l

—

(3028717) Thiamine [Mass/volume] in Blood

3.76

1.93

1.0

1.3

—

(3021901) Oxygen saturation in Capillary blood

250

1.57

1.93

2.8

2.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.45

1.93

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

120

1.84

1.93

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.12

1.92

1.5

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

150

1.74

1.91

1.3

1.6

—

(3042631) Mycobacterium sp identified in Specimen

182

1.66

1.85

2.5

2.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.40

1.85

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.40

1.85

1.4

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.54

1.84

1.3

2.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.54

1.84

2.7

2.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.54

1.84

1.2

1.4

0.76

0.99

mg/l

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

137

1.76

1.83

3.6

3.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.18

1.82

8.8

10.3

—

(3030313) Adrenal Ab [Titer] in Serum

4.18

1.82

1.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

262

1.54

1.82

1.5

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.35

1.77

1.5

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.35

1.77

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

169

1.67

1.77

1.3

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

162

1.68

1.75

1.4

334.62

371.77

pmol/l

0.19

141

(3000330) Specific gravity of Urine by Test strip

682

1.32

1.73

3.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.67

1.72

1.5

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.67

1.72

1.5

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.67

1.72

1.5

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

103

1.85

1.72

1.2

1.1

—

5.00

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.85

1.71

1.0

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

226

1.56

1.71

1.5

1.9

—

1330.00

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.16

1.66

2.5

1.6

—

(3008898) HLA-B27 [Presence]

608

1.33

1.65

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

112

1.79

1.64

1.2

1.1

—

75.89

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

173

1.63

1.64

1.7

1.6

59.90

57.89

0.11

109

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.58

1.61

1.2

1.0

0.41

7.73

u/ml

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

222

1.54

1.60

1.4

1.5

—

(3017509) Phencyclidine [Presence] in Urine

3.01

1.58

5.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.70

1.58

1.3

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

239

1.52

1.58

2.9

2.7

5.45

6.49

umol/l

0.29

173

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.21

1.57

1.5

117.09

88.31

nmol/24h

0.25

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.60

1.51

1.6

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.86

1.50

2.5

2.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.86

1.50

2.7

2.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.86

1.50

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

154

1.63

1.50

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

342

1.41

1.49

1.3

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

101

1.79

1.49

2.2

2.9

45.26

44.23

—

(3003694) ABO and Rh group [Type] in Blood

493

4512

1.13

1.47

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

310

1.43

1.46

1.4

1.5

151.29

119.56

u/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

414

0.65

1.46

1.6

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

294

1.44

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

228

1.50

1.44

1.7

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

261

1.47

1.44

1.3

1.2

3.07

3.44

u/ml

0.06

(3023199) Leukocytes [#/volume] in Pleural fluid

149

1.62

1.41

1.6

1.4

4046.56

1646.73

e6/l

0.42

105

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

214

1.50

1.38

1.4

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

455

0.68

1.37

1.5

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

2.61

1.36

1.3

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

191

1.53

1.35

1.2

1.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

1.34

0.0

1.1

—

19.70

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

1.33

0.0

6.7

—

(3047189) Immunofixation for 24 hour Urine

1.97

1.33

2.7

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

202

1753

1.17

1.31

4.7

4.2

32.66

31.98

0.42

152

1248

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

121

1.66

1.31

1.7

1.4

162.97

239.53

pmol/l

0.46

121

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

304

2720

1.14

1.30

3.0

2.9

0.59

0.75

ug/l

4.00

222

1726

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

205

1786

1.17

1.27

1.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.40

1.24

1.3

1.4

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.64

1.21

3.0

3.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.64

1.21

1.2

3.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

280

1.40

1.21

1.1

—

11.63

—

(3045424) Erythrocytes [Presence] in Urine

255

1.42

1.20

1.8

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

349

1.36

1.20

1.2

1.1

1.68

2.81

u/ml

0.55

181

(3035880) pH of Pleural fluid

1.84

1.19

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

189

1.49

1.19

1.1

97.52

95.02

0.16

178

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

256

1.41

1.18

1.3

1.2

4.14

5.42

u/ml

0.28

112

(3036071) Salmonella sp Ab [Titer] in Serum

1.88

1.18

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

935

0.79

1.17

1.4

1.5

—

(3037121) Protein [Mass/volume] in Urine

545

1.28

1.15

3.6

0.27

0.29

g/l

0.07

243

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.50

1.15

3.2

3.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.50

1.15

1.8

1.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

1.15

0.0

6.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

118

1.62

1.15

1.6

1.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.14

0.0

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

250

1.41

1.13

1.6

1.4

18.50

21.58

u/l

0.32

207

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

175

1.49

1.13

2.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

135

1.56

1.11

1.0

1.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

184

1.47

1.11

1.4

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

184

1.47

1.11

1.4

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

193

1.46

1.09

1.4

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.38

1.09

1.0

—

(40761536) Microorganisms panel - Urine sediment

154

1332

1.17

1.07

5.8

3.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

178

1.47

1.05

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

306

1.35

1.04

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

114

1.58

1.02

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

307

1.34

1.02

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.92

1.02

5.0

2.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

356

0.70

1.00

1.2

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

248

1.38

1.00

1.1

1.0

6.30

4.39

u/ml

0.32

122

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

164

1.47

0.99

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.72

0.99

1.2

1.1

1721.62

1629.87

miu/ml

0.09

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.97

0.0

1.0

—

-3.45

—

(3006598) pH of Arterial cord blood

0.00

0.97

0.0

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

624

1.23

0.95

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

1.77

0.94

1.8

1.6

—

(3012441) Differential panel - Pleural fluid

133

1.51

0.94

1.5

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

133

1.51

0.94

1.6

1.4

9464.07

28709.30

e6/l

1.11

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

365

1.30

0.93

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

295

1.33

0.93

1.2

1.1

2.68

1.66

u/ml

0.44

152

(3023430) Cat dander IgE Ab [Units/volume] in Serum

226

1.38

0.92

1.1

7.68

4.84

u/ml

0.23

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.07

0.89

1.0

1.2

—

(3045788) Cell count panel - Pleural fluid

119

1.52

0.88

1.5

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.79

0.88

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.79

0.88

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.86

0.87

2.1

3.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.86

0.87

2.1

3.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.00

0.87

1.7

2.1

—

(3000034) Microalbumin [Mass/volume] in Urine

128

1.49

0.86

2.3

3.2

5.17

45.78

mg/l

1.88

(3020876) Protein [Mass/time] in 24 hour Urine

145

1.45

0.85

3.1

2.7

0.82

1.35

g/24h

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.60

0.84

1.5

1.3

12.66

26.66

umol/l

3.78

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.76

0.83

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.71

0.80

3.1

2.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

250

1.33

0.80

1.2

114.11

115.51

0.08

228

(3003888) Timothy IgE Ab [Units/volume] in Serum

312

1.29

0.79

1.1

7.95

5.62

u/ml

0.49

173

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.79

0.0

8.0

—

(4034850) Laboratory test

484

1.23

0.78

10.6

9.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

616

0.81

0.77

1.3

1.4

—

(3034426) Prothrombin time (PT)

1.70

0.75

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

141

1.42

0.74

2.8

2.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

557

0.80

0.73

1.4

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

108

1.49

0.73

1.0

—

(3044927) Protein electrophoresis panel - Urine

150

1.40

0.73

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.00

0.72

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

159

1.39

0.72

3.3

2.6

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.62

0.71

1.6

2.4

20.81

140.40

ug/l

0.48

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.55

0.69

1.1

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.53

0.69

1.1

1.2

—

(4035726) Immunohistochemistry procedure

143

1279

1.13

0.69

1.3

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

170

1.36

0.67

1.5

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

348

1.24

0.66

1.3

264.48

250.13

u/ml

0.13

212

(3002619) Bacteria identified in Specimen by Culture

1.79

0.66

1.0

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

259

1.28

0.65

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

112

1.43

0.63

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.64

0.62

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.67

0.61

1.0

1.2

0.02

0.96

u/ml

—

(40757373) Influenza virus identified in Isolate

1.67

0.61

1.8

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.60

0.61

1.4

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.60

0.0

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.57

0.60

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.57

0.60

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.59

0.0

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

131

1.38

0.59

1.9

2.3

—

(3006462) Nitrate [Presence] in Urine

1.57

0.58

1.4

2.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

246

1.26

0.58

3.8

3.1

0.82

0.87

nmol/l

0.31

192

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.72

0.57

1.5

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

457

1.19

0.57

3.5

4.5

1.38

1.47

mg/l

0.40

429

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

256

1.25

0.56

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

1.54

0.55

1.2

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

116

1.38

0.54

1.3

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

535

0.84

0.54

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

322

1.22

0.53

2.6

2.2

1.01

0.85

nmol/l

0.51

274

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.50

0.51

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

260

1.23

0.51

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

162

1.30

0.50

1.8

2.4

36.11

22.63

mg/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

110

1.37

0.48

1.1

—

(3024263) Appearance of Synovial fluid

1.45

0.48

1.1

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

208

1.25

0.48

1.0

0.20

0.31

u/ml

0.20

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

129

1.32

0.45

1.1

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

129

1.32

0.45

1.6

1.4

5.86

6.75

mmol/l

0.68

119

(3001019) Free T4 and TSH panel - Serum or Plasma

916

0.89

0.45

1.8

1.7

—

(3045142) Bone marrow Pathology biopsy report

165

1.28

0.45

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

302

1.20

0.44

1.1

0.50

1.31

u/ml

1.01

131

(3017569) Oxygen content in Arterial blood

1.45

0.44

1.5

3.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.61

0.43

1.2

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.61

0.43

1.2

3.5

58.00

75.44

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

532

0.86

0.43

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.43

0.42

2.6

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.56

0.42

1.2

1.1

—

(3048879) Bone marrow aspiration report

1.56

0.42

1.0

1.9

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.56

0.42

1.6

1.3

39.80

23.74

—

(3013637) Mi-2 Ab [Presence] in Serum

1.56

0.42

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.56

0.42

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.56

0.42

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.41

0.42

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.43

0.41

1.2

1.4

151.90

164.62

mmol/24h

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

231

1.22

0.41

1.3

1.2

29.26

39.33

u/l

0.34

195

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.41

0.0

1.0

—

11.67

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.47

0.40

1.6

1.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.40

0.0

1.0

—

159.78

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.34

0.38

1.1

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.33

0.37

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

1.35

0.37

1.6

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

1.29

0.36

44.7

31.9

130.44

130.36

ug/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

375

1.15

0.36

1.4

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

491

0.87

0.36

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

117

1.28

0.35

1.3

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

490

0.87

0.35

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.37

0.34

2.6

3.9

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

172

1.22

0.34

2.0

2.3

34.33

32.55

1.13

172

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

489

0.88

0.34

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

163

1.23

0.34

3.5

3.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

488

0.88

0.33

1.4

—

(3028433) Virus identified in Specimen by Culture

1.28

0.32

1.3

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.28

0.28

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.28

0.26

1.8

2.8

382.45

1114.60

u/ml

1.75

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.30

0.26

1.3

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.30

0.26

1.3

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.22

0.25

1.3

1.1

84.44

92.38

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

114

1.23

0.25

1.1

—

(3000012) Reticulocyte production index

179

1.18

0.25

1.5

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

193

1847

1.05

0.25

1.5

1.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

137

0.80

0.24

1.5

1.6

8.25

7.71

mmol/l

0.30

131

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.17

0.24

1.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.17

0.24

1.2

1.6

—

(3004451) EKG impression Narrative

1.17

0.24

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.28

0.24

1.7

2.8

—

(4281824) Cell count and differential, peritoneal fluid

143

1.19

0.23

1.4

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.25

0.22

1.2

1.4

2.52

3.62

mmol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

116

1.21

0.22

2.3

0.86

2.32

u/field

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.19

0.21

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

4.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

3.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

1.25

0.20

2.1

2.0

3.70

3.08

ug/l

—

(3017704) Immunofixation for Urine

1.25

0.20

1.8

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

229

0.87

0.20

3.6

4.0

29.50

30.55

u/ml

0.03

223

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

185

0.86

0.18

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

227

0.88

0.18

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

100

1.20

0.18

1.2

1.1

0.76

2.98

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

101

1.19

0.16

1.1

0.80

1.91

u/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.21

0.15

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

119

0.84

0.15

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

399

0.93

0.14

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.18

0.14

1.3

1.5

—

(3015183) Erythrocyte sedimentation rate

0.79

0.14

1.3

1.2

—

(3020491) Glucose [Moles/volume] in Blood

112

1.16

0.14

1.9

2.2

7.13

6.63

mmol/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

354

1.07

0.13

2.0

2.3

227.81

109.06

ug/min

0.36

219

(3043238) Trisomy 21 risk [Likelihood] in Fetus

407

0.93

0.13

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

648

1.05

0.13

1.3

1.7

3.94

4.36

mg/l

0.13

470

(3005033) Fetal Nuchal fold Thickness US

396

0.93

0.12

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

492

1.06

0.12

2.3

3.5

608.72

2875.69

u/ml

0.55

420

(40768800) Prostate Pathology biopsy report

288

1.08

0.11

1.2

—

(40768806) Pleura Pathology biopsy report

134

1.12

0.11

1.8

1.6

—

(4146454) Self-monitoring of blood glucose

145

1.10

0.09

3.3

2.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

250

2541

0.98

0.09

1.5

—

(21494434) Karyotype in Bone marrow

134

0.89

0.08

1.5

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.05

0.08

2.0

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

318

0.94

0.08

3.6

3.7

21.45

24.14

mg/l

0.12

203

(40765089) Chromosome analysis panel - Blood by G-banded

0.82

0.08

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

117

1.11

0.08

1.7

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.86

0.07

1.0

1.1

299.33

210.76

iu/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.12

0.07

2.1

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.82

0.07

1.2

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

131

1338

0.98

0.07

3.4

4.2

5.62

19.58

ug/l

1.33

108

1079

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.84

0.07

1.1

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.05

0.07

1.1

—

16.25

—

(40768795) Lymph node Pathology biopsy report

142

0.91

0.06

1.3

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

102

0.88

0.06

1.1

1.4

1.65

1.55

g/l

—

102

(3005570) Glucose [Moles/volume] in Urine

162

0.93

0.06

5.9

2.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

120

0.92

0.05

1.4

1.5

0.99

0.98

g/l

0.01

120

(40768793) Breast Pathology biopsy report

342

0.96

0.04

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

199

0.95

0.03

2.4

2.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

108

0.93

0.03

1.0

1.8

—

(40768441) Liver Pathology biopsy report

118

0.93

0.02

1.6

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

135

1.04

0.00

2.1

1.4

45.33

30.78

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

189

1.01

0.00

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

116

1.03

0.00

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

332

0.99

0.00

4.2

4.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

113

0.97

0.00

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

247

1.01

0.00

1.1

2.28

2.32

u/ml

—

111

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

180

1797

1.00

0.00

1.5

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.96

0.00

1.6

2.6

—

45196.30

—

(3024471) HLA-A [Type]

0.88

-0.00

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

-0.00

0.0

1.8

—

2.63

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

0.05

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

-0.00

0.0

1.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.1

—

407.86

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.0

—

39.94

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.01

-0.00

1.1

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.80

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

-0.00

0.0

1.7

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.8

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

-0.00

0.0

1.0

—

177.80

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

188.57

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3024932) HLA-DR beta [Type]

0.89

-0.00

1.0

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

0.19

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.02

-0.00

2.2

1.4

12.86

8.84

ug/l

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.7

—

1.50

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_CRAMP_SPASM – Cramp and spasm

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cramp and spasm

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Cramp and spasm (R18_CRAMP_SPASM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints